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1.1 The head: a vertebrate invention 
 
In this project I have used Xenopus laevis to address the spatial and temporal 
requirements for various signaling pathways in organogenesis, specifically 
craniofacial development. Craniofacial structures of Xenopus, such as the cartilages, 
are analogous to those in other vertebrates. A significant portion of the vertebrate 
head is derived from the neural crest. Thus, this is also a study of neural crest 
development.   
 
 The vertebrate head can be defined by the presence of a number of specialised 
features including a segmented brain, complex sensory organs and others such as 
skull bones, teeth and facial muscles. This developmental biology project strives to 
understand how various signaling pathways regulate the development of this 
complex, multicellular, three-dimensional region. Moreover, I am interested in how 
the neural crest can contribute to these wide-ranging structures.  
 
The unique features of the head help set vertebrates apart from cephalochordates, 
their closest non-vertebrate relatives (Stone and Hall, 2004) (Wada, 2001). One 
such close relative is Amphioxus, which has a notochord and a neural tube, but does 
not possess a complex brain or any complex facial structures. Crucially, it lacks the 
neural crest cells that comprise the head structures of vertebrates. In 
cephalochordate and urochordate embryos the cells in the border between the 
neural plate and the epidermis express several key genes required for vertebrate 
crest development (Snail, Msx, Bmp2, Pax3) (Meulemans and Bronner-Fraser, 
2007; Yu et al., 2008). Unlike vertebrate crest, these cells are not migratory and do 
not have the same pluripotency of vertebrate neural crest cells (Holland and 
Holland, 2001). As such, the innovation of migratory neural crest cells is integral to 




1.1.1 Craniofacial malformations  
 
Errors in the development of cranial neural crest or in disruption in normal 
embryogenesis can result in a wide variety of craniofacial abnormalities.  These 
abnormalities have far reaching implications for patients: the inability to eat, 
breathe, speak, or hear normally may result in severe difficulties during childhood 
that can persist into adulthood or, are sometimes fatal. Craniofacial abnormalities 
are among the most common birth defects and approximately one-third of all 
human congenital defects will present with craniofacial dysmorphologies. However, 
only a limited number of these disorders are well characterised and little is known 
about the etiology of these craniofacial disorders. Some are known to be primarily 
genetic in nature (e.g. Treacher Collins syndrome, Crouzon Syndrome or DiGeorge 
syndrome (Trainor, 2010; Trainor et al., 2009) (Reardon et al., 1994) (Wurdak et al., 
2006)) while others are presumed to be caused by environmental factors (e.g. fetal 
alcohol syndrome (Ulleland, 1972)). Often multiple factors play roles in determining 
the severity of these disorders.  
 
Recent advances in the generation of mouse and zebrafish mutants have shed some 
light on certain craniofacial syndromes. This said, generation of mutant models is 
time consuming and expensive. Though more models are now becoming available 
(e.g. Jackson laboratory genetic resource centre http://www.jax.org/), animal 
phenotypes may not be comparable to those in human patients. Mutant models have 
also been generated in forward mutagenesis screens (discussed later). These are 
extremely useful in shedding light on the requirements for specific genes. However, 
early defects can mask later roles in development and thus may not be ideal models 
for studying human dysmorphologies. For example, the sonic hedgehog (SHH) gene 
is known to be mutated in human craniofacial disorders. However, mice lacking Shh 
die early in gestation (Chiang et al., 1996). Conditional mutants, such as those 
generated by Cre-dependent gene excision, can bypass embryonic lethality (Sauer, 
1987). Such inducible technologies are remarkably useful when looking at the 
function of a specific gene in a specific tissue, or, at a set time in development. This 
approach assumes availability of multiple transgenic mouse lines, which may be too 
expensive for most labs. In my project, we made use of Xenopus as an alternative 
model system for neural crest and craniofacial development.  
 
 
1.2 The neural crest  
 
The neural crest is a uniquely vertebrate, migratory cell population that arises in the 
dorsal region of the neural tube and contributes to both head and trunk. Neural crest 
(NC) arise bilaterally at the border of the non-neural ectoderm and the neural plate 
and can be identified by expression of a unique panel of genes, including slug 
(snail2), snail, sox10, sox9, foxD3 and c-myc (Linker et al., 2000; Mayor et al., 
1995) (Sasai et al., 2001) (Spokony et al., 2002) (Nieto, 2002) (Honore et al., 2003). 
Neural crest cells are specified throughout the neural tube, posterior to the mid-
hindbrain boundary. After neural tube closure, neural crest cells delaminate from 
the most dorsal region of the neural tube by undergoing an epithelial–mesenchymal 
transition (EMT). Crest cells then migrate throughout the embryo via distinct, 
conserved paths. After migration, neural crest cells populate specific regions along 
the length of the embryo and differentiate into multiple cell types during 
organogenesis. NC cells not only differentiate into skeletal elements of the head but 
are capable of forming connective tissue, Schwann cells, sensory ganglia, and 
melanocytes (Aybar et al., 2002) (Knecht and Bronner-Fraser, 2002) (Sauka-
Spengler and Bronner-Fraser, 2008). Organs that receive a contribution from the 
neural crest include the optic vesicle, the inner ear, cranial nerves and the 
pharyngeal arches, where neural crest derived tissue form muscle, bone, and 
cartilage of the face (Le Douarin and Kalcheim, 1999).  
 
As neural crest is integral to so many tissues, correct NC development is crucial for 
embryogenesis. Resulting phenotypes of improper NC development are dramatic 
and varied. They include cleft palate, intestinal aganglionosis (Hirschsprung's 
disease) and cancers such as neuroblastoma (Fuchs and Sommer, 2007; Tobin et al., 
2008a). As such, neurocristopathies (disorders of the neural crest) are often 
pleiotrophic syndromes affecting many tissues. A more detailed understanding of 
neural crest development will, therefore, provide insight into a large number of 




1.2.1 Neural crest induction 
 
A complex set of signaling pathways, discussed in more detail later, regulate 
induction of the neural crest (Aybar et al., 2002) (Knecht and Bronner-Fraser, 





Figure 1.1 Some of the tissues and signals involved in neural crest induction 
The induction of neural crest cells (in green) occurs at the border of the neural plate (blue) 
and the surface ectoderm (yellow). Neural crest induction depends on signaling between 
non-neural ectoderm and the neural plate. Signals from the paraxial mesoderm are also 
important. 
(Sauka-Spengler and Bronner-Fraser, 2008) 
 
 
As the neural tube elevates and closes, multiple signals specify the neural crest cells 
in the region between the neural plate and the surface non-neural ectoderm. 
Gradients of signaling factors are established during early embryogenesis. These 
include high-levels of BMP from the non-neural ectoderm, FGF from the paraxial 
mesoderm, and Wnt from the non-neural ectoderm and paraxial mesoderm (Figure 
1.1) (Mancilla and Mayor, 1996) (Marchant et al., 1998) (García-Castro and Bronner-
Fraser, 1999).  A number of Wnts are required for neural crest during development. 
In Xenopus these include Wnt1, Wnt3A (in presumptive neural crest) and Wnt7b (in 
the neural plate and non-neural ectoderm) (Wu et al., 2005). Wnt8 is present in the 
underlying mesoderm and the Wnt receptor Frizzled (Fz3/9) is expressed in the 
surrounding ectoderm (Wu et al., 2003). Wnt signaling in neural crest development 
is explored in detail later.  
 
NC induction is initiated during early gastrula stages and may proceed during later 
neurula stages. Experiments in frog and chick embryos have shown that cell–cell 
interactions in the ectoderm are required to ensure NC development. There must be 
interaction between the non-neural ectoderm and the neural ectoderm (neural 
plate) in order to induce NC (Moury and Jacobson, 1990; Selleck and Bronner-
Fraser, 1995) (Dickinson et al., 1995) (Mancilla and Mayor, 1996). Paraxial 
mesoderm is required to induce NC in the adjacent neural folds region (Selleck and 
Bronner-Fraser, 1995) (Bonstein et al., 1998). During gastrulation and early 
neurulation, this paraxial mesoderm lies beneath the presumptive neural crest.  
However, this interaction is not required during Zebrafish neural crest induction as 
excision of paraxial mesoderm does not cause loss of neural crest and MZoep 
(‘maternal-zygotic one-eyed pinhead’) mutants which lack paraxial mesoderm have 
normal neural crest (Ragland and Raible, 2004).  
 
 
1.2.2 Neural crest delamination occurs via epithelial to mesenchymal 
transition  
 
The neural crest arises from epithelial cells which are polarised and held together 
tightly by intercellular junctions (Tucker, 2004). The neural crest then delaminate in 
a process called epithelial to mesenchymal transition (EMT) during which the basal 
lamina of the dorsal neural tube breaks down, intercellular junctions weaken and 
cells are free to migrate (Tucker, 2004) (Kang and Svoboda, 2005). In the neural 
crest, delamination is tightly linked to the cell cycle. Neural crest cells delaminate 
during the S phase (Burstyn-Cohen et al., 2004). Wnt/β-catenin signaling is 
required indirectly, for controlling cell cycle progression from G1 to S phase by 
regulating the transcription of cyclin D1 (Tetsu and McCormick, 1999). This Wnt 
activity during delamination of the neural crest may be regulated by BMP (Burstyn-
Cohen et al., 2004).  Up regulation of BMP results in increased neural crest 
migration, a phenotype rescued with the addition of β-catenin. When β-catenin is 
over expressed, neural crest migration is lost (Burstyn-Cohen et al., 2004). Slug, a 
member of the snail family, is expressed in NC cells and promotes loss of epithelial 
characteristics as well as halting of cell cycle. These changes are crucial and have 
also been found in metastatic cancer cells (Nieto, 2002; Vega et al., 2004). Slug is a 
transcriptional target of Wnt/β-catenin signaling (Vallin et al., 2001). In chick and 
Xenopus, inhibition of slug after neural crest induction results in neural crest cells 




Figure 1.2 Delamination of Epithelial Cells  
Epithelial cells are strictly polarised with apical, basal and lateral surfaces and are held 
tightly together with several types of intercellular junctions.  The adherens junctions are 
composed of numerous E-cadherin molecules. In the transition from epithelial to 
mesenchymal cells, E-cadherin expression is downregulated, allowing attached epithelial 
cells to separate from each other and take on a mesenchymal phenotype. Mesenchymal 
cells can migrate through the extracellular matrix. In addition to loss of E-cadherin, there is 
often misregulated expression of N-cadherin in mesenchymal cells that has been linked to 
their increased motility.  




1.2.3 Numerous external factors regulate migration of the neural crest 
 
Trunk and cranial neural crest cells migrate along specific routes, unique to either 
population (Kuriyama and Mayor, 2008). Cranial neural crest cells migrate in a 
wave over a short period of time, compared to the more lengthy period of migration 
in the trunk neural crest cells (Hall, 2008) (Le Douarin and Kalcheim, 1999) 
(Théveneau et al., 2007). The paths taken by the migrating cells are specific and 
regulated by both attractive and repulsive forces, which are different depending on 
where the cells are located along the anterior-posterior (A-P) axis (Abzhanov et al., 
2003). There are numerous molecules involved in generating the attractive or 
repulsive forces, including semaphorins/neuropilins, ephs/ephrins, chemokines, 
complements and ADAMs such as ADAM13 (Alfandari et al., 2001; Carmona-
Fontaine et al., 2011; Gammill et al., 2007; Olesnicky Killian et al., 2009; Rezzoug et 
al., 2011; Robinson et al., 1997; Smith et al., 1997) 
 
Cranial neural crest paths are initially determined by rhombomeres of the 
developing brain. Neural crest cells arise from all the rhombomeres (r) of the chick 
brain, with some apoptosis is seen in the premigratory cells of r3 and r5 (Ellies et al., 
2002). After delamination the neural crest cells (NCCs) sort into streams below the 
2nd, 4th and 6th rhombomeres (Birgbauer et al., 1995). In Xenopus, organisation of 
the migratory streams occurs somewhat later and begins when the cells move into 
the branchial arches (Sadaghiani and Thiébaud, 1987; Smith et al., 1997). Prior to 
this the cells migrate close to the surface ectoderm in the embryo (Kuriyama and 
Mayor, 2008).  
 
The cranial neural crest streams in the mouse are maintained by coordination of 
neuropilin 2 and semaphorin 3F expression (Gammill et al., 2007) (Eickholt et al., 
1999). Rhombomeres and somites express semaphorin 3F while migrating neural 
crest cells express neuropilin 2 (Gammill et al., 2006; Osborne et al., 2005).  Various 
Eph/ephrin combinations are found in mouse and chick and have been shown to 
regulate the migration of the neural crest cells around and through the anterior 
somites of the trunk (Santiago and Erickson, 2002). In both zebrafish and chick it 
has been shown that cranial neural crest cells express receptors Cxcr4 and Cxcr7 and 
that the expression the chemokine Sdf1 in pharyngeal arch is required for proper 
migration and subsequent differentiation of cranial crest (Olesnicky Killian et al., 
2009; Rezzoug et al., 2011). Neural crest cells, upon first delamination, move as 
sheets of cells with contact between the cells that are important for proper 
migration. This cell-cell interaction requires close coordination between cells and 
recently it has been shown that the cells are not only receiving attractive and 
repulsive forces from their surrounding tissues but also from one another. These 
signals support the cohesive nature of the neural crest, are crucial for the collective 
migration and are mediated by the complement fragment C3a and its receptor C3aR 
(Carmona-Fontaine et al., 2011). Additionally, ADAMs have been found to have a 
role in regulating cranial neural crest migration (Seals and Courtneidge, 2003).  
Loss of ADAM13 in Xenopus cranial crest results in failure of these cells to migrate. 
Aberrant expression in trunk cells causes the NCCs to migrate into pathways they 
are normally prohibited from, suggesting the ADAMs are required for the cells to 
interpret the permissive or repulsive messages in their surrounding (Alfandari et al., 
2001). Alternatively, ADAM13 may be regulating the NCCs ability to travel on 




Figure 1.3 Signals guiding neural crest migration   
 
Neural crest cells express a variety of cell surface receptors. The cephalic (cranial) and trunk 
crest express different receptors.  The tissues surrounding the migrating crest have several 
positive (shown in green) and negative (shown in red) guidance cues. Certain molecules, 
such as ephrins/Eph may act as permissive or restrictive cues. Working together, these 
create the pathways for migration and maintain NC free regions in the body.  
Figure from (Theveneau and Mayor, 2012) 
 
Such attractive and repulsive forces work by regulating the direction of migration 
and either permitting or preventing cell migration in any given direction.  In the case 
of semaphorins and chemokines, altering the cyctoskeletal support in the projection 
on the leading edge of the cell regulates direction of migration. Sema3 interaction 
with its neurophilin1 receptor induces growth cone collapse in neurons by activating 
GSK-3 at the cone edge (Eickholt et al., 2002), suggesting a potential role for GSK-3 
in the leading edge of a migrating neural crest cell. Loss of semaphorin activity in 
chick and zebrafish results in neural crest invading tissues that should be devoid of 
neural crest (Osborne et al., 2005) (Yu and Moens, 2005).  
 
1.2.4 Differentiation of the Neural Crest 
 
A number of factors have been implicated in the regulation of neural crest 
differentiation. These include the timing and route of their migration. Timing of 
neural crest delamination is important for the NC specification of in both chick and 
mouse (Serbedzija et al., 1994) (Henion and Weston, 1997) Lysinated rhodamine 
dextran tracing was used to label individual chick NCCs and all subsequent progeny. 
Injections performed early in the migration (E8-9) contributed to a much wider 
range of derivatives than those injected between stages E9-10 (Serbedzija et al., 
1994). In mouse, in vitro clonal analysis was used to show that many neural crest 
cells are fate restricted, even in the premigratory stages. The later migrating cells 
express melanocyte markers, not found in cells that were migrating from the earlier 
explants (Henion and Weston, 1997). Late migrating neural crest cells in chick 
contribute significantly more than early migrating cells to skeletal elements of the 
face (Henion and Weston, 1997) while in mouse later emigration of cells results in 
dorsal fates such as dorsal root ganglia (Serbedzija et al., 1994). Melanocytes arise 
from the later migration of trunk neural crest (Wilson et al., 2004).   
 
Neural crest cells traverse a number of different routes and these routes affect the 
differential fate of the cells (Wilson et al., 2004). The neural crest cells are exposed 
to a number of different factors that may affect survival and differentiation choices 
(Sieber-Blum and Zhang, 1997).  Trunk neural crest cells migrate through either the 
ventral pathway to become neuronal and contribute to the dorsal root ganglia or 
take the more dorsal-lateral route to become cells such as melanocytes (Wilson et 
al., 2004). The importance of pathway was shown by quail/chick hybrid experiments 
when quail trunk cells were transplanted into the cranial region of a chick where 
they differentiated into cranial appropriate cholinergic neurons (Le Douarin and 
Kalcheim, 1999).  
 
Though it is not yet clear exactly what in vivo signals each cell population is exposed 
to while migrating and how these cells coordinate these signals to determine their 
differentiation, some work in cell culture demonstrated that changes in exposure to 
certain signaling molecules, including various endothelins, Wnt signals, or 
neurotrophins can alter fate decision in migrating NC cells (Sauka-Spengler and 
Bronner-Fraser, 2008). For example, increased Wnt/β−catenin signaling pushes 
NCCs to a neuronal cell fate (Lee et al., 2004). 
 
1.3 Key signaling pathways in development  
 
1.3.1 Hedgehog signaling  
 
The hedgehog pathway (Hh) is highly conserved signaling pathway important in 
most organisms (Bürglin and Kuwabara, 2006). Much of the work identifying the 
key players took place in Drosophila (Ingham et al., 2011). Hh was first discovered 
in a mutagenesis screen identifying genes controlling the spatial organisation of the 
Drosophila body plan (Nüsslein-Volhard and Wieschaus, 1980). In mammals, three 
homologues of Hh have been identified: sonic hedgehog (shh), indian hedgehog 
(ihh) and desert hedgegog (dhh) (Echelard et al., 1993). Of these, Shh is the best 
studied and is of great importance during development. In mammals, inhibition of 
the Hedgehog pathway results in severe congenital anomalies, ranging from cyclopia 
and holoprosencephaly to milder effects such as a single maxillary incisor (Hu and 
Helms, 1999). Recent genome wide studies have identified numerous potential 
targets for Gli signaling. (Vokes et al., 2007) (Vokes et al., 2008) 
 
1.3.1.1 Hedgehog ligands 
 
All Hh ligands are initially secreted as large precursor molecules of approximately 
45kDa in size that require significant post-translational modification (Lee et al., 
1994) (Pepinsky et al., 1998). The first of these modifications involves cleavage of 
the immature peptide into two fragments: leaving an active 19kDa N-terminal 
fragment (Hh-N) and a 25kDa C-terminal fragment (Lee et al., 1994). The active 
signaling fragment is further modified by the addition of two lipid moieties. In a 
reaction unique to vertebrate Hedgehog, a cholesterol molecule is added to the C-
terminal of Hh-N. This reaction is catalysed by the C-terminal fragment of the Hh 
peptide itself (Beachy et al., 1997). Additionally a cysteine residue at the N-terminal 
of Hh-N is palmitoylated (Pepinsky et al., 1998). In the absence of these lipid 
additions, Hedgehog signaling is lost (Lewis et al., 2001) (Chen et al., 2004).  
 1.3.1.2 Hedgehog signal transduction 
 
Hedgehog has an unusual signal transduction. When mature Shh is secreted, it is 
sequestered by a 12-pass transmembrane receptor Patched (Ptc) (Marigo et al., 
1996) (Stone et al., 1996) (Ingham et al., 1991). In vertebrates, two distinct Ptc 
receptors have been identified (Ptc1 and Ptc2). Both receptors bind the Shh ligand 
with similar affinity (Carpenter et al., 1998). In the absence of Shh ligand, Ptc 
associates with and inhibits a 7-pass G-protein coupled receptor Smoothened (Smo) 
(Stone et al., 1996). In the presence of ligand, Ptc inhibition is relieved, and 
Smoothened (Smo) activates downstream signaling. 
 
1.3.1.3 Intracellular signaling 
 
In Drosophila, the intracellular transducer of Hh signaling is the zinc finger 
transcription factor cubitus interruptus (Ci) (Alexandre et al., 1996). The vertebrate 
homologues of Ci are the Gli transcription factors. Three have been identified: Gli1, 
Gli2 and Gli3 (Hui et al., 1994). Gli1 and Gli2 are generally regarded as activator 
Glis; indeed Gli1 does not possess a repressor domain. This phosphorylation of Gli1 
and Gli2 promotes their cytoplasmic degradation. In the absence of this 
phosphorylation they translocate to the nucleus and induce transcription of target 
genes (Sasaki et al., 1999). In contrast, phosphorylation of Gli3 results in its cleavage 
where it subsequently translocates to the nucleus to act as a transcriptional 
repressor. Hedgehog ligands block this repressor function by inhibiting Gli3 
cleavage (Dai et al., 1999; Price and Kalderon, 2002). The Hedgehog signaling 
pathway is autoregulatory. Multiple components of the pathway, including Ptc1 and 





1.3.1.4 Hedgehog signaling is linked to specific locations on the cell membrane 
 
Recent evidence suggests that Hedgehog signaling in vertebrates is closely 
associated with primary cilia (Zaghloul and Katsanis, 2009). Here, in the absence of 
Shh signaling, Ptc is localised to the base of the cilium inhibiting Smo activity. On 
activation of Shh signaling, Ptc relocates and Smo moves in to the cilium (Wilson 
and Stainier, 2010) (Goetz et al., 2009) (Goetz and Anderson, 2010). Perturbations 
in ciliogenesis result in hedgehog-like defects (reviewed in (Fliegauf et al., 2007) 

































 1.3.2 Roles for Hedgehog signaling in development  
 
Hedgehogs are absolutely required for normal embryonic development. The role of 
Shh in craniofacial development is especially well documented. In humans and mice, 
loss of function mutations in Shh are responsible for holoprosencephaly, a disorder 
characterised by a failure of the forebrain to divide and defects in the facial midline 
(Roessler et al., 1996). Over activation of the Shh pathway, either through 
overexpression of Shh, or the loss of Ptc (leading to constitutive activation of Smo), 
is also developmentally deleterious. In humans, mutations in PTC are associated 
with basal cell nevus syndrome, a disorder causing developmental defects and 
tumors, especially basal cell carcinomas (BCCs). Similarly, mice overexpressing Shh 
in the skin develop BCCs (Johnson et al., 1996) (Oro et al., 1997). 
 
Shh is an especially interesting ligand because it can participate in either short or 
long range signaling depending on the biological context. Because the mature 
peptide is associated with lipid modifications, Shh was originally believed to be 
membrane associated and therefore only able to signal at short range. However, it 
has now been shown that a highly stable multimeric form of Shh is capable of free 
diffusion and thus can act as a morphogen (Goetz et al., 2006) (Zeng et al., 2001). A 
classic example of Shh’s ability to act as a morphogen is during vertebrate limb 
development, demonstrated through experiments using the chicken limb. Prior to 
digit patterning, Shh is expressed in a defined region (the “zone of polarising 
activity”) of the posterior limb bud (Riddle et al., 1993). This results in the formation 
of a gradient of Shh along the posterior to anterior axis of the developing limb 
(Lewis et al., 2001). This gradient plays an important role in specifying the anterior-
posterior pattern of the limb and in the types of digits that are formed (Yang et al., 
1997). Gradients in hedgehog signaling are also known to regulate the dorsal-ventral 
identity of neurons from the neural tube. Shh expression from the ventral notochord 
creates a ventral-dorsal gradient in signal strength what results in the specification 




1.3.3 Hedgehog is essential for neural crest development  
 
Hedgehog signaling has two crucial roles in neural crest development, ensuring 
survival and regulating differentiation. Shh from the anterior endoderm and 
prechordal plate is required for the survival of neural crest cells early in the 
migration of the cranial crest population (Ahlgren and Bronner-Fraser, 1999) (Brito 
et al., 2006) (Jeong et al., 2004). Inhibition of Shh by removal of source tissue or by 
blocking of signal using antibodies causes increased NCC death and craniofacial 
defects.   
 
Later, Shh signaling plays a role in regulation of the differentiation of the neural 
crest into cartilage and neurons. NCCs that have migrated into the face require 
signaling from underlying tissues for proper morphogenic movements and cranial 
cartilage patterning (Wada et al., 2005). Neural crest cells that populate the gut 
depend on Shh signaling to proliferate and generate the enteric nervous system (Fu 
et al., 2004). Cell culture assays have shown that Shh signaling has the potential to 
orient NCC migration in the gut by restricting its migration (Fu et al., 2004). It may 
also regulate the differentiation into neurons (Fu et al., 2004; Ungos et al., 2003) 
(Calloni et al., 2007).  
 
1.3.4 Wnt signaling 
 
The Wnts are a family of secreted, highly conserved, cysteine-rich glycoproteins 
involved in many key aspects of morphogenesis and embryonic development. The 
pathway is used repeatedly throughout development with temporal and spatial 
requirements during development of many organs (Wodarz and Nusse, 1998).  
 
The name Wnt was coined based on the phenotype in Drosophila melanogaster 
(wingless) and the homologous region in the mouse Int1 locus.  These two genes, 
mouse Wnt-1, first identified in 1982 (Nusse and Varmus, 1982) and Wingless, 
identified in 1987 (Cabrera et al., 1987) (Rijsewijk et al., 1987) were just the first 
genes identified in what would become the Wnt family. Mutations in various Wnt 
genes have shown the importance of this pathway in processes ranging from 
segmentation in Drosophila, to gut development in C.elegans and axis formation in 
Xenopus (Wodarz and Nusse, 1998).  
 There are two Wnt signaling pathways, the canonical and the non-canonical 
pathway (see Figure 1.3). Outlined below are the two segments of the non-canonical 
pathways (in green and brown, Figure 1.3) and the canonical pathway (in blue, 
Figure 1.3). Recently, it has been shown that traditional assumptions attributing 
Wnt ligand/Frizzled receptor combinations to specific branches of Wnt pathways 
may be erroneous. Wnt 11, long assumed to be required solely for non-canonical 
signaling, can induce β-catenin signaling during axis formation in Xenopus, a 
canonical Wnt function (Tao et al., 2005). The question of how the signal is correctly 
interpreted by the cell upon binding of a Wnt ligand is therefore still open to debate, 
though it is likely that the regulation of cell membrane complexes play a large role. 
(Cha et al., 2009) (Cha et al., 2008)  
 
1.3.4.1 Canonical Wnt signaling 
 
The canonical Wnt pathway is mediated by β-catenin with Wnt ligands activating a 
series of complex signaling cascades. In resting cells, an inhibitory “destruction” 
complex phosphorylates the transcriptional co-activator β-catenin, targeting it for 
degradation. This complex is comprised of Axin, glycogen synthase kinase-3 (GSK-
3) and other proteins. Upon binding of Wnt ligands to Frizzled cell-surface receptors 
and the transmembrane protein LRP, the intracellular signaling phospho-protein, 
Dishevelled, inhibits the destruction complex.  GSK-3 no longer phosphorylates β-
catenin, thereby halting the ubiquitination and subsequent degradation of β-catenin 
via proteolytic degradation. β−catenin is then free to accumulate in the cell, 
translocate to the nucleus where it replaces the inhibitory molecule Groucho in a 
complex with T-cell specific transcription factor (Tcf) or lymphoid enhancer-binding 
factor 1 (Lef) transcription factors. This β-catenin-Tcf/Lef transcription complex 
then induces target gene transcription (Salic et al., 2000) (Logan and Nusse, 2004). 
Target genes are widespread, and the Wnt homepage, kept by the Nusse lab at 






1.3.4.2 Non-canonical Wnt signaling 
 
Wnt signaling independent of β-catenin constitutes the non-canonical Wnt signaling 
pathways. These include Wnt/calcium signaling, Wnt/JNK signaling and Wnt/PCP 
signaling (Rao and Kühl, 2010).  
 
Planer cell polarity (PCP) signaling is responsible for asymmetrical and polarised 
localisation of proteins in cells including epithelia, giving rise to daughter cells with 
different cellular components, reviewed in (Dale et al., 2009). Wnt/JNK signaling 
involves the activation of small GTPases, which include Rac, Rho and JNK itself and 
like PCP signaling, regulates polarised cell movements (reviewed in (Rao and Kühl, 
2010)).  
 
Wnt/calcium signaling relies on mediation by G-proteins to release a wave of 
calcium ions. When released, this activates Ca++ dependent downstream targets 
that include calcineurin, reviewed in (Rao and Kühl, 2010). Wnt/Ca+ signaling is 
thought to have a role in mediating canonical Wnt activity in dorsal-ventral 
patterning of the early Xenopus embryo as dominant negative NF-AT mutants have 
ectopic dorsal structures and non-inhibitable NF-AT mutants lose anterior 




















1.3.5 Wnt signaling is important throughout development  
 
The Wnt pathway is another signaling pathway that is used repeatedly in 
development.  Most important for this project is the role of Wnt in the induction of 
two uniquely vertebrate structures: the head and the neural crest.  
 
Speciﬁcation of axial identity in the embryo is determined by a concerted effort from 
numerous genes.  The details regarding this patterning were first discovered in the 
1920’s with the identification of “the organiser”, a region of the early gastrula that is 
patterned before the rest of the embryo and induces primary induction of the 
dorsal/ventral axis. The organiser is found in the anterior portion of the dorsal 
blastopore lip in the early Xenopus gastrula (Harland, 2008). In the 1950’s it was 
shown that this early event is preceded by anterior/posterior axis formation. It was 
found that a gradient of an unknown signal confers increasingly posterior tissue 
identity with increased signal strength (Harland and Gerhart, 1997). This signal was 
later identified to be Wnt and it was found that properly regulated Wnt signaling is 
crucial for anterior-posterior (A-P) identity (Domingos et al., 2001).  During 
gastrulation in vertebrates this difference in Wnt signaling translates into a body 
plan, instructing the developing embryo where the “head” and “tail” should be.  In 
fact, a high level of posterior Wnt signaling combined with inhibition of Wnt in the 
anterior is a conserved principle of vertebrate axial development (Yamaguchi, 2001).  
 
A number of Wnt inhibitors including Cerberus (cer), Dickkopf (Dkk), and Frzb are 
secreted by the anterior in the gastrula. Together, they maintain Wnt inhibition, 
thereby, acting as an inducer of head structures (Glinka et al., 1998) (Kazanskaya et 
al., 2000) (Mao et al., 2001).  Alterations to the inhibition of Wnt in the anterior, 
such as loss of dkk-1 or over expression of non-inhibitable β−catenin, result in 
increased anterior Wnt signaling. This shift causes a loss of head structures 
(Heasman et al., 1994). Dkk-1 mutant mice display a range of microcephaly with null 
mutants losing anterior head structures completely (MacDonald et al., 2004).  
Conversely, when β−catenin is knocked down with antisense morpholino 
oligonucleotides (MO) injection or overexpression of glycogen synthase kinase -3 
(GSK-3, an inhibitor of Wnt signaling), expression of the anterior head marker, 




1.3.6 The many roles for Wnt signaling in neural crest induction 
 
In every biological model system examined, Wnt signaling is required for NC 
induction (Dorsky et al., 1998) (Brault et al., 2001) (García-Castro et al., 2002; Ikeya 
et al., 1997; Saint-Jeannet et al., 1997) (Chang and Hemmati-Brivanlou, 1998) 
(Lewis et al., 2004) (LaBonne and Bronner-Fraser, 1998) (Steventon et al., 2005). 
Studies in Xenopus show that regulation of Wnt signal is required at two time 
points, first in the induction of neural tissue then in regionalization of neural tissue.  
Wnt is then directly responsible for the expression neural crest specific genes. The 
first is during early gastrulation when Wnt/β−catenin signaling and BMP signaling 
are inhibited in the ectoderm to allow specification of neural tissue. Later, Wnt 
signals that determine both anterior–posterior and mediolateral positioning are 
required for neural crest induction. At this point in the early neurula, Wnt8a is 
expressed in the lateral and ventral mesoderm underlying the presumptive neural 
crest (Christian et al., 1991). Wnt1 and Wnt3a are expressed in the ectoderm in the 
same region as slug (Wolda et al., 1993). Wnt activity is required for induction of the 
neural crest. Indeed slug, the earliest neural crest specific marker, has Lef/β−catenin 
binding sites in its promoter region and is directly regulated by Wnt signaling 
(Vallin et al., 2001). The anterior neural plate, where neural crest is not induced, 
actively prevents Wnt signaling with expression of Wnt inhibitors in the underlying 
prechordal mesoderm such as dickkopf-1 (dkk-1) (Carmona-Fontaine et al., 2007). 
 
In Xenopus and chick embryos, overexpressing components of the canonical Wnt 
pathway like frizzled, Lrp6, or β-catenin expanded the region fated to be NC as did 
ectopic expression of canonical Wnt ligands (Chang and Hemmati-Brivanlou, 1998) 
(LaBonne and Bronner-Fraser, 1998) (Saint-Jeannet et al., 1997). In contrast, 
inhibiting Wnt signaling by over expressing GSK-3 reduces induction of the NC 







1.3.7 BMP signaling 
 
 
Bone Morphogenetic Proteins (BMPs), are members of the Transforming Growth 
Factor β (TGFβ) family of ligands. BMP signaling regulates a hugely diverse range of 
events in the developing embryo. The BMP family of secreted signaling molecules 
consists of over 20 identified members. The BMPs, with the exception of BMP1 (a 
metalloprotease, an enzyme where the catalytic activity requires a metal ion, 
typically zinc), belong to the TGFβ super family along with the TGFβs and activins. 
Within the family of secreted growth factors, the BMPs can be further divided 
according to their homology to ancestral genes. BMP2 and BMP4 are grouped 
together as the decapentaplegic (dpp) subfamily due to their homology with the 
Drosophila dpp gene. BMP5 to 8 are the 60A subfamily because they are 
homologous to Drosophila 60A (Kingsley, 1994) (Massagué, 2000).  
 
The BMPs act through the BMP receptors (BMPRs), transmembrane proteins with 
specific serine-threonine kinase activity. The receptors consist of a ligand binding 
extracellular domain and an intracellular domain associated with kinase activity. 
There are two types of receptors BMPRI and BMPRII respectively with Type 1 
receptors having higher affinity for BMP binding (Wrana et al., 1994) (Kirsch et al., 
2000).  
 
BMP ligands are dimers and the monomers containing binding sites for Type I and 
Type II receptors. For signaling to proceed the Bmp ligand must bind to Type I and 
Type II receptors, forming a multimeric complex. The Type II receptor 
phosphorylates serine-threonine residues within a conserved intracellular region of 
the bound Type I receptor (Wrana et al., 1994), stimulating the Type I receptor 
kinase activity. This causes the phosphorylation of the cytoplasmic signaling 
molecules, Receptor-activated Smads (RSmads). BMP receptors phosphorylate 
specific RSmads (1, 5 and 8), distinct from those RSmads2 and 3 involved in TGF 
and activin signaling. Phosphorylation induces RSmads to form a complex with an 
unphosphorylated co-Smad, Smad4. This complex then translocates to the nucleus, 
where it is able to affect the transcription of target genes (Massagué and Chen, 
2000).  
 
BMP signaling, like most intracellular signaling pathways, is highly regulated. To 
overcome the problems of specificity given the few signaling molecules used 
downstream of BMP, nuclear cofactors are incorporated to modulate transcriptional 
control by the Smad complex once it has entered the nucleus (Massagué and 
Wotton, 2000). Negative regulation of the pathway occurs at the point of ligand-
receptor binding. Soluble proteins such as Noggin and Chordin prevent binding of 
BMPs to their receptors (Abreu et al., 2002; Massagué and Wotton, 2000). These 
signals can be induced as a result of other signaling pathways or by BMP itself.  It 
should be noted that BMP signaling can occur in a Smad independent manner such 
as the mitogen activated protein kinase MAPK cascade, not discussed further in this 
thesis (Derynck and Zhang, 2003). It is now believed that BMP signaling, using 
SMADS to relay signals to the nucleus, draws on a large number of co-factors that 
modify gene targets depending on the cellular environment  
 
1.3.8 BMP signaling in development 
 
The BMPs, initially discovered to play a role in bone formation, have since been 
shown to have diverse functions during vertebrate and invertebrate embryogenesis 
(Hogan, 1996; Urist, 1965). BMPs are required in early embryonic development, 
when Bmp4 and inhibitors Chordin and Noggin are expressed in an opposing 
fashion in the early embryonic mesoderm, where they regulate dorsal-ventral 
patterning (Hogan, 1996). The BMP agonists Chordin and Noggin have roles in 
developmental events as diverse as forebrain development, mandibular outgrowth 
and left-right asymmetry (Bachiller et al., 2000; Mine et al., 2008; Stottmann et al., 
2001).  
 
In establishing the left and right body plan, levels of BMP signaling are regulated by 
expression of the antagonists Noggin and Chordin. Errors in the this patterning 
result in erroneous development of such asymmetric organs as the heart, lungs, 
liver, spleen and intestines as w ell as the vascular system (Mine et al., 2008). Later 
roles include regulation of the outgrowth of the mandible. Here both Noggin and 
Chordin are expressed in the developing branchial arches. Loss of both genes results 
in hypoplasia of the developing mandible due to cell death of the cells in this region 
(Stottmann et al., 2001).  
 
1.4 Biological screens  
 
Numerous model organisms have been used for scientific research over time but 
amphibia have long been popular for developmental biology research.  As such, in 
vivo chemical screens have been performed for generations. Sea urchin eggs, newt 
spawn and frog spawn were popular choices for these early experiments. However, 
researchers performing these early screens noted that these experiments could only 
be performed during spring when spawn was available. It would be another few 
decades before frog spawning would be induced using hormone preparations, 
discussed below.  
 
1.4.1 Why is Xenopus a model organism? 
 
Xenopus is an aquatic, externally developing animal with large clutches, making it 
particularly suited to screening experiments. The 1mm eggs are easily cultured in 96 
well plates and the tadpoles do not require feeding for many days.  
 
Today the most commonly used research organisms are yeast, C. elegans, 
Drosophila, zebrafish, Xenopus laevis and tropicalis, chick and mouse.  Each offers 
advantages and disadvantages but for this project I will describe zebrafish and 
Xenopus, which are well suited to chemical screens addressing temporal 
requirements of signaling in development of vertebrate organs. Both are aquatic, 
externally developing animals with reasonable clutch sizes (100-200 for zebrafish 
and 1000+ for Xenopus) and zebrafish offers most of the same early advantages as 
Xenopus.  The critical time points in neural crest development are identified and 
occur stereotypically, offering the opportunity to manipulate signaling during 
specific key events in development (LaBonne and Bronner-Fraser, 1999) (Henion et 
al., 1996) (Kelsh et al., 1996; Neuhauss et al., 1996) (Chang and Hemmati-Brivanlou, 
1998).  
 
1.4.2 Xenopus laevis: history of a research model  
 
Xenopus laevis is often lauded as a great animal model for early embryological 
studies; however, it was not an obvious choice for a developmental model.  A South 
African native, Xenopus was initially studied as a comparative curiosity.  As a short-
tongued frog, it is distinct from those found readily in Europe (including the popular 
Rana) yet it became the dominant embryological research model during the 50’s and 
60’s.  This was predominantly due to two factors: 1) Xenopus became a popular and 
trustworthy laboratory readout for pregnancy in post-war Europe and US, so 
numerous colonies in hospital labs provided readily accessible eggs to researchers 
year round; 2) during this time, researchers were making great strides in techniques 
that allowed biochemical and cellular questions to be addressed. Therefore, the use 
of Xenopus was expanded beyond developmental biologists by researchers in other 
fields (reviewed in (Gurdon and Hopwood, 2000)). 
 
Xenopus eggs are well suited for use in chemical screens. Their large size and robust 
nature makes them ideal for early manipulations. The predictable, temperature 
sensitive development of Xenopus, is a useful tool for studying discrete 
developmental events.  Together these traits offer the researcher the opportunity to 
have 1000’s of embryos developing in unison that can be cultured in a multitude of 
conditions.   
 
In this project, I demonstrate the utility of Xenopus for chemical screens (chapters 
three to four). In chapter five, I describe a novel role for Hedgehog signaling in 
specification of the primary mouth. Chapter six defines a role for glycogen synthase 
kinase 3 (GSK-3) in neural crest migration and contributions to craniofacial 
development. Finally, in chapter seven, I describe collaborative work defining 
interactions between Gli proteins and GSK-3, which uncover previously an unknown 
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 2.1 Embryo collection  
 
Xenopus laevis live in fresh water and sexually mature females can be induced to lay 
hundreds of eggs. Embryos were obtained by inducing ovulation via injection of 350 
– 500 units of human Chorionic Gonadotropin (hCG) into the dorsal lymph sac 
approximately 16 hours before eggs were required. Eggs were then collected by 
gentle “squeezing” and were fertilised by in vitro fertilisation using a piece of testis 
isolated from a male. Males were sacrificed by an overdose of the anaesthetic MS-
222 (50% in H2O) injected into the dorsal lymph sac. Isolated testes were stored at 
4°C in 1XMR (Marc’s Ringer) and 0.050mg/ml gentamicin antibiotic. A small piece 
of testis was cut and macerated in the Petri dish containing eggs with 0.5ml 
dechlorinated tap water. Embryos were flooded with 1/3X MR and transferred to 
incubators at appropriate temperatures. The jelly coat was removed from the eggs 
after the first cleavage by incubating in 2% cysteine pH8 (Smith and Slack, 1983) for 
3-4mins followed by 5 washes in H2O and a final 3 washes in 1/3xMMR. The 
embryos are grown in 1/3xMMR at 14°c or 19°c to the appropriate stage in 
accordance with Nieuwkoop and Faber, 1967. Unfertilised, dead or dying embryos 
were removed and media was changed regularly to maintain clean conditions. 
 
2.2 Fixation 
Embryos were fixed in MEMFA for 1 hour at room temperature or overnight at 4°C. 
Embryos were then washed twice in MeOH and stored in MeOH. Samples were 
stored at -20°C until processing. Post processing, embryos were fixed overnight in 
MEMFA and stored at room temperature in MeOH unless otherwise stated.  
 
2.3 DNA preparation   
 
To transform bacterial cells 1µg of plasmid DNA was added to a 25µl volume of 
DH1α competent cells and incubated on ice for 20 minutes. The cell solution was 
then heat shocked at 42°C for 1 minute and returned to ice for 2 minutes. 200µl of 
LB media were added to the solution, 100µl of which is spread on a 50mg/mL 
ampicillin LB agar plate and this was grown overnight at 37°C. A single colony was 
then picked using a clean pipette tip. This tip was placed in a flask of LB media 
containing 50ug/ml ampicillin and incubated over night (no more than 16 hours) at 
37°C on a shaker. When the colony reached appropriate density, measured by loss of 
transparency of the LB media, the recombinant plasmid DNA was isolated using the 
Qiagen plasmid mini or midi kit and protocol. 
 
2.4 DNA restriction digests  
 
10µg circular Mini or Midi prep DNA was cut using a restriction endonuclease 
(source: Promega or NEB) in a 1 x reaction buffer mix at 37°C for 2 hrs: 
 
10µg DNA 
5µl 5 x Buffer 
2µl Restriction enzyme 
Made to 50µl H2O 
 
DNA was analysed using agarose gel electrophoresis to confirm that it had been 
completely linearised as DNA templates for RNA transcription must be fully 
linearised for efficient transcription. If DNA was not fully linearised 2µl enzyme was 
added and the reaction was incubated at 37°C for a further 2hrs. The DNA was 
cleaned using Qiagen mini or midi prep kit. DNA was treated with Proteinase K 
(sigma), phenol chloroform extracted and ethanol precipitated then the DNA 
resuspended in nuclease free water to give a concentration of 1μg/μl.  
 
2.5 RNA synthesis  
 
Synthetic capped mRNA for microinjection was made using the mMessage 
mMachine kit (Ambion) and DNA templates listed in table below. mRNA was eluted 
and cleaned using NucAway Spin Columns (Ambion) before elution in 100μl RNA-
ase free/nuclease free H2O. 5μl was taken for qualitative analysis on a 1% 
TAE/agarose gel. 0.1μl of ethidium bromide was added to allow visualisation of the 
DNA on an electrophoresis gel. The 5.1μl was denatured at 85°C for 10mins and run 
out on the agarose gel to ensure mRNA was correct length and good quality. A 
second aliquot of 5μl was made up to 100μl using RNase free H2O and quantified 
using a spectrophotometer.  
 2.6 In situ hybridisation probe synthesis  
 
Antisense RNA probes were prepared using appropriately linearised plasmids as 
templates and transcribed with SP6 or T7 polymerases (Promega) as described by 
Harland and Weintraub 1985. Plasmids were linearised using the indicated 
restriction enzymes and incubated at 37°C for 2hours. Proteins from this 
linearisation were removed by PK treatment at 55°C for 15mins and the now linear 
template cleaned using phenol : chloroform extraction. Templates were resuspended 
in DNase free H2O at a concentration of 1ug/μl. Dig labeled in situ hybridisation 
probes were synthesised using DIG-Labeling Mix (Roche), precipitated in half 
volume 8M LiCl at -80°C and washed in 70% EtOH. The pellet was resuspended in 
55μl H2O. 2.5μl were taken and run on a gel as above. 2.5μl was also taken and 
quantified as above. The remaining volume was added to hybridisation buffer at 








Probe Linearised with Run from Reference 
GSK-3α EcoR1  T7 Cloned from EST 
AccNo:BG364215 
GSK-3β EcoR1 SP6 Harland lab 
collection No. 675 
Twist EcoR1 T7 (Hopwood et al., 
1989) 
Slug Nco1 SP6 (Grammer et al., 
2000) 
Sox9 Sal1 T7 Liu lab collection 
No: 25 
Otx2 Not1 T7 Monsoro-burq lab 
collection No.303 
Six1 No1 T7 Monsoro-burq lab 
collection No.1771 
Krox 20 Not1  T3  
Pax6 EcoR1 SP6 Monsoro-burq lab 
collection No.522 
Ptc-2 Not1 T7 AccNo: AB037688 
Shh Ecor1 T7  
Table 2.1: Probe synthesis  
2.7 Microinjection 
 
De-jellied embryos were put onto the mesh grid in a petri dish filled with 1/3xMMR 
and 2% Ficoll. Ficoll is a high molecular weight polysaccharide and is used in this 
media to remove the fluid from within the vitelline membrane via an osmotic 
gradient. This makes the embryo easier to inject and reduces the volume of cellular 
leakage, resulting from injection. Build up of cellular fluids between the embryo and 
vitelline membrane can kill the embryo. The micropipettes were calibrated by 
injecting mRNA into the surface of a dish of mineral oil and measuring the diameter 
of the ejected mRNA using an eyepiece graticule. The desired injection volumes were 
crudely changed by trimming the micropipette using forceps and finely adjusted by 
changing pressure and duration of expulsion. To express mRNA in the whole 
embryo or large regions of the embryo, embryos were injected at the 2 or 4 cell stage. 
To keep expression restricted to specific tissues, such as the neural crest, embryos 
were injected at the 32cell stage using the 32-cell stage fate map as a guide. Lineage 
labeling was performed by co injection of mini ruby dextran. 
 
2.8 Drug screen  
 
Embryos are collected and fertilised, dejellied and washed into 1/3X MMR. Drug 
dilutions of the required concentrations are made in culture media (Table 3.1) and 
embryos are transferred into 24 well plates. For the initial screen two concentrations 
of each drug were made and 10 embryos were cultured per well. Initial examination 
of phenotypes was catalogued in embryos exposed to drug at 2-cell stage and 
allowed to develop stage 45. No wash out was performed and the drug solution was 
not refreshed. Embryos were monitored daily and dead embryos removed.  
 
Further treatments were performed using those drugs that generated interesting 
phenotypes (Table 3.2). To establish whether the perturbed pathway had roles at 
distinct times in development and whether the phenotypes seen at stage 45 could be 
attributed to perturbations at specific time points in development, embryos were 
exposed to drug during short periods. Embryos were transferred to 24 well plates, 10 
per well and exposed to 1/3x MMR solution containing drug at 1) 2 cell stage until 
stage 45, 2) at stage 12.5 until stage 19, 3) at stage 19 until stage 37 or 4) stage 37 
until stage 45. Embryos were kept in 1/3X MMR before the drug treatment. Drug 
was added at the appropriate stage by transferring the embryos to a new well 
containing the appropriate 1/3x MMR/drug solution. To remove the drug the media 
containing the drug was drawn off, the embryos rinsed 3 times in fresh 1/3x MMR 
before finally transferring them to a new 24 well plate with fresh 1/3x MMR. All 
embryos were allowed to develop to stage 45. In control embryos the same washes 
were performed to ensure that if the handling caused any phenotypes, they would be 
identifiable in the controls.  
 
Certain parameters were established to ensure that experimental phenotypes were 
indeed a result of the drug, not caused by natural defects or illness. In any given 
batch of embryos, if 30% or more of the controls developed atypically the batch was 
discounted. This was crucially important as on many occasions the control embryos 
developed with severe anterior defects (lack of a cement gland, narrow head etc). 
Such batches were not scored in the experiments.  If 30% of more of the controls 
died the batch was also discounted. These measures did result in the loss of 
numerous experiments but were essential in protecting the results from any 
variation due to changes in the maternal environment, disease or stress that could 
have adversely affected the embryo quality.  
 
2.9 Wholemount mRNA in situ hybridisation (WISH) 
 
Embryos for whole mount mRNA in situ hybridisation were prepared by collecting 
at the appropriate stage. Embryos were fixed in MEMFA for 1 hour at room 
temperature, the vitelline membrane was removed and the embryos bleached in 0.5x 
SSC, 5% formamide, 1% H2O2 then dehydrated into methanol and stored at -20°C 
until further processing. Embryos older than stage 28 were first anesthetised in 0.1% 
benzocaine then fixed. All in situ hybridisations were developed in BM purple 
substrate. Whole-mount in situ hybridisation was done according to Harland 1991 
with the following modifications:  Proteinase K step and post PK fixation step were 
removed so WISH was performed as follows: 
Day 1.  
Embryo were bleached using solution of 1% H2O2, 5% formamide in MeOH in clear 
glass bottles under bright light. Embryos were not rolled during bleaching as this 
often caused damage to the brittle embryos. The samples were then rehydrated step 
wise from 100% MeOH into 100% PBS+0.1% Tween (Ptw) at RT (5 mins at each step 
75%MeOH/25% H2O, 50%MeOH/50% H2O, 25%MeOH/75% PTw, then 100% in 
PTw). Embryos were then washed 3x5mins in PTw at room temperature before 
being sorted into baskets. These baskets, made from eppendorfs with the bottom cut 
off and fine pore mesh glued on, can hold up to 10 embryos and allow for easy 
handling of the samples throughout the various washes.   
Once separated, embryos were incubated 2x5 mins in 0.1M triethanolamine pH 7-8 
before addition of acetic anhydride (12.5µl in 5mls).  This acetic anhydride addition 
was repeated and incubated for 5mins at RT. Embryos were washed in PTw 2x5mins 
at RT them transferred to hybridisation solution at 60°C for 1hour. This pre-probe 
hybridisation was removed and replaced with 0.5ml of probe solution (1µg/ml 
probe) and hybridised overnight at 60°C. 
Day 2.  
Probe was removed, stored for future use at -20°C, and embryos were returned to 
the pre-hybridisation solution at 60°C for 10mins.  
Embryos were washed in 2xSSC at 60°C for 3x20mins then incubated in 2xSSC with 
RNAse A (20µg/ml) and RNAse T1 (10µg/ml) for 30mins at 37°C. This was followed 
by a 10min wash in 2xSSC at RT and 2x30min washed in 0.2xSSC at 60°C. 
Embryos were then washed in maleic acid buffer (MAB) for 2x10min at RT before 
incubation in MAB+2%BMB blocking agent (Boehringer Mannheim Blocking 
solution) either o/n for 1hr at RT.  Anti-digoxygenin AP antibody was added to this 
(1:3000) and the embryos incubated o/n at 4°C.  
Day 3:  
Embryos were washed in MAB for 1x5 hours followed by 2x5min washes in alkaline 
phosphatase buffer. Baskets were then transferred to a 48 well plate, 0.5ml of BM 
purple (Boehringer Mannheim) added to each well and the whole dish covered with 
tinfoil to allow the colour to develop in the dark. If probes had been used previously, 
the first 30mins of development was done at 37°C as this increased the rate of 
reaction. Alternatively this was done at RT and the colour checked every 30-40mins.  
Once the stain has reached the required depth the process was stopped by a MAB 
wash (5 mins RT). Embryos were then post-fixed in bouins fix o/n at 4°C. This 
turned the embryos bright yellow and numerous washes in PTw were required to 
remove the yellow colour. When embryos had returned to the appropriate colour 
(purple stain with white background) they were photographed. This could be done in 
PTw or if a visualisation of a deeper stain was required, embryos were dehydrated 
into 100% MeOH and washed into benzyl benzoate/benzyl alcohol (BB:BA) clearing 
agent. This was only performed in glass watch clock dishes and embryos were not 
kept in BB:BA for extensive periods as it will cause the purple stain to fade. Embryos 
were then washed into MeOH for long-term storage.  
 
2.10  Wholemount immunohistochemistry 
 
Embryos were aged to the appropriate stages, dissected out of their vitelline 
membranes and fixed in MEMFA for 1hour at room temperature, the vitelline 
membrane was removed and the embryos bleached in 0.5x SSC, 5% formamide, 1% 
H2O2dehydrated into methanol and stored at -20°C until further processing. 
Embryos older than stage 28 were first anesthetised in 0.1% benzocaine before 
fixation. Embryos were rehydrated in stepwise fashion; 75% MeOH, 50% MeOH, 
25% MeOH to PBS. Embryos were washed in 1xPBS+0.1% tween and preblocked in 
1xPBS+0.1% tween with 10% heat inactivated goat serum. Embryos were incubated 
with primary antibodies overnight at 4°C. Embryos were washed for 3x2hours in 
1xPBS+0,1% tween at room temperature then incubated with secondary antibodies 
overnight at 4°C. Alexa 514 fluorophore is preferable as it is distinct from the 
autofluorescence of the gut. Embryos developed with fluorescent secondary 
antibodies were photographed after 3x 2hour washes in 1xPBS+0.1% tween. Non-
fluorescent staining was done using HRP conjugated antibodies and DAB. Embryos 
being stained with DAB were bleached prior to primary antibody incubation.  
 
2.11 Immunohistochemistry on wax sections  
 
Embryos for sectioning were dehydrated into 100% MeOH then embedded using the 
following protocol:  
Solution Wash duration  
100% IMS  0:30 




Ultraplast Wax 0:30 
Ultraplast Wax 0:30 
Ultraplast Wax 0:30 
 
Sections were cut 11µM thick and were mounted on slides in a 3 slide sequential 
manner. As each ribbon was mounted, the first section was placed on slide 1, the 
second on slide 2 and the third on slide 3. This was repeated until all sections were 
mounted.  Sections were mounted onto flat cool slides wet with a small amount of 
30% EtOH: 70% water. When the slide was full they were transferred to a hot rack at 
40°C and baked until the slides were dry (2-3 hours). If the sections were not 
smoothing out, additional EtOH : water solution could be added to help remove 
wrinkles. When dry, slides were moved to an oven and baked overnight at 40°C. 
They were stored in covered trays at 4°C until stained.  
 
Slides were dewaxed in histoclear 2x 2mins followed be rehydration in a stepwise 
fashion (5 min washes in 100%. 90%, 80%, 70%, 50%, 30%, EtOH). Slides were 
washed in PBS 2x2mins then PTx for 5mins. Antigen retrieval was achieved by 
microwaving the samples for 4x4mins in 10mM sodium citrate. Solutions were 
topped up between heating with pure H2O. The slides and solution was then cooled 
on ice and when RT, washed back into PBS 2x 2mins. To block, slides were placed in 
slide trays, lying flat and covered with sufficient PBT + 10% sheep serum to cover. 
Cover slips of appropriately trimmed parafilm were overlaid and the slides 
incubated at room temperature for 40mins. Block solution was drawn off using a 
fine tipped plastic pipette and the primary antibody added in the same manner as 
the block. The slides were incubated at 1:300 primary antibody in block solution 
overnight at 4°C. Slides were washed in PBT 3x 10mins then blocked again as before. 
Secondary antibody was applied as primary at 1:300 + DAPI at 1;1000, cover slipped 
and kept dark for 1hr at RT. Slides were washed in PBT 4x10mins then PBS 2x 
5mins. Slides were mounted with mowiol and protected by placing appropriate sized 
glass coverslips over the slides.  
 
2.12  Wholemount cartilage staining 
 
Stage 45+ embryos were fixed in MEMFA for 1 hour at room temperature before 
washing into EtOH. Embryos can be stored at -20°C at this stage. For cartilage 
staining embryos were washing into a 0.15% alcian blue solution (70% EtOH/30% 
acetic acid) and left to wash at room temperature for 3 days. Solution may be 
replaced during the 3 days if the Alcian blue dye precipitates. When suitably stained, 
embryos were rinsed 3x 15 mins in 95% EtOH. Rehydration was done stepwise into 
2% KOH then washed from 2%KOH stepwise into 80% glycerol/20% 2%KOH, 1 
hour per wash before washing overnight into the final solution. Dissection of 
cartilages was then performed to increase visibility of craniofacial cartilages.  
 
2.13  Western blotting 
 
Western blots were used to detect protein levels in Xenopus lysates. Embryos were 
collected at the appropriate stages and frozen in minimal liquid at -80°C. Lysates 
were prepared by homogenizing embryos into RIPA (radioimmunoprecipitation 
assay buffer). Lysates were spun down for 10mins. The supernatant was removed 
carefully leaving a pellet and fatty layer. This was repeated twice more. An equal 
amount of SDS loading buffer was added to the remaining supernatant and the 
proteins denatured at 90°C for 5mins before quick spin.  This sample can stored at -
20°C.  
Samples, equal to ¼ of an embryo were loaded into a well of a 4-12% gradient gel, 
run at 160V for 45 mins. Semi dry transfer onto PVDF membrane was performed at 
15V for 45mins. Membranes were rinsed in water then methanol before drying 
completely. Membranes can be stored by dehydration in MeOH before probing. To 
probe for protein, membranes were rehydrated by a wash in MeOH, clean water 
then TBS. Membranes were blocked incubating in a 50-ml conical tube containing 
TBS + 10% fat free milk (Cell signaling no:9999) and 0.1% bovine serum albumin 
(BSA) on a automatic roller at RT for 1hour. Primary antibody was applied at 1:200 
– 1:1000 depending on the antibody in block solution and blots left overnight at 4°C. 
Membranes were washed in TBSTw for 3x 20 mins then blocked again as before. 
Secondary antibody was applied as primary at 1:30,000 – 1:50,000 depending on 
primary antibody and incubated at RT for 1hour. Membranes were washed 3x 
20mins TBSTw then developed using immobilon western chemiluminescent HRP 
substrate  (Immobolin kit no: WKBL S01 00).  
 
2.14 Hematoxylin and Eosin staining 
  
Hematoxylin is a stain that marks basophilic structures such as chromatin or 
ribosomes a deep purple, providing a clear view of the cell nuclei. Eosin is an acidic 
stain that stains acidicophilic structures red. It stains the cell membranes clearly. 
(Ehrlich, 1886).  Slide mounted sections were dewaxed with 2x10 minute Histo-
clearTM washes and rehydrated stepwise in ethanol washes (100%, 90%, 70% and 
50%) for 2 minutes each.  Slides were washed in distilled water before a 10min 
incubation in Erhlich’s Haematoxylin (Solemedia).  Excess haematoxylin was 
removed by washing the samples for 10 minutes under running water.  For Eosin 
staining to contrast, slides were rinsed in distilled water and then submerged in acid 
alcohol for 15 seconds.  Slides were then stained with 0.5% aqueous Eosin (Lamb) 
for 2 minutes, washed in distilled water and dehydrated stepwise in a series of two 
minute ethanol washes (70%, 90% and two 100%).  Sections were air-dried for 1 
hour before being cover-slipped (VWR) with DePex (Solemedia). 
 
2.15 Luciferase assay 
 
Embryos were injected in both blastomeres at the 2-cell stage with either 
SuperTopFlash (STF) or GliBS reporter construct (ref).  Embryos were cultured in 
various conditions to stage 14 before being transferred individually to wells in a 96 
well plate. Lysates were prepared by pipetting up and down rapidly in 50μl of 1x 
passive lysis buffer (promega kit E1910). 25μl of lysate was transferred to a suitable 
white 96 well plate, which was placed in the luminometer. Automatic injections were 
set up to add 25μl of luciferase assay regent 1 (LAR1) to each well. Firefly luciferase 
activity was measured for each well in the plate. Regents from dual-luciferase 




Images were taken using a Nikon SMZ1500, a stereomicroscope with a zoom range 
of 0.75x to 11.25x and edited using Adobe Photoshop. 
 
2.16.1 Confocal imaging  
 
Single-photon microscopy was performed using a Leica TCS SP5 DM16000 confocal 
microscope. Appropriate lasers were used according to the secondary fluorophores 
used during immunostaining. Alexa 488 was excited with the Argon laser (488), 
Alexa 568 and To-PRO was excited using the DPSS 561 laser and DAPI was excited 
using the 405 diode. Collection filters were set using the Leica defaults where 488 
emissions were collected between 496 and 558μM, 568 emissions were colleted from 
596-712μM. Images were captured using a HCXPLAPO CS 0.7na dry X20 or oil wet 
X40 objective.  
2.17 Data analysis and statistics 
In all of the screening experiments, at least 21 samples were assessed for each 
condition. All screening figures show representative samples. The minimum number 
of embryos examined per treatment are provided in the figure legends. 
 
For quantitative measurements of embryo dimensions, 12 embryos were chosen at 
random from each condition. The mean, as well as error bars denoting the standard 
error of the mean (SEM), are shown for each measurement. P values were generated 
using the Student’s t-test. 
 
Where the percentage of embryos displaying a specific phenotype is shown, the 
number is rounded to the closest whole number. 
 
2.18 List of solutions  
1X Modified Marcs Ringer Solution  
100mM  NaCL 
2mM   KCL 
1mM   MgCl2 
2mM   CaCL2 
5mM   HEPES. pH 7.5 
 
Stored at room temperature in 5L drums. 1/3xMMR was used for general embryo 
culture and 1/3xMMR + 2% Ficoll was used for embryo manipulations.  
10X PBS (pH 7.5) 
80mM  Na2HPO4 
20mM  NaH2PO4.2(H2O) 
100mM NaCl 
Made with nuclease free  H2O. pH adjusted and autoclaved. 
PBSTw (PTw) 
1X PBS + 0.1% Tween 
PBSTx (PTx) 
1X PBS + 0.1% Triton 20 
TBSTw  
1X TBS + 0.1% Tween  
20X SSC:  
3M   NaCl 
0.3M   Tri-sodium citrate 
pH adjusted to 7.5 with NaOH, autoclaved and stored at room temperature. 
MEMFA fixative  
0.1M   MOPS pH 7.4 
2mM   EGTA 
1mM   Magnesium sulphate 
3.7%   Formaldehyde 
Hybridisation buffer:  
50%   Formamide (molecular grade) 
5X   SSC  
5mg/ml Torula RNA (stock at 25mg/ml in 50% Formamide (molecular 
grade)) 
100µl/ml  Heparin 
1 X   Denhardts solution 
0.1%   Tween-20 
0.1%   Chaps 
0.25mM EDTA 
Alkaline Phosphatase Buffer: 
100mM Tris-HCL pH 9.5 
50mM  MgCl2 
100mM NaCl 
5mM  Levamisole 
0.1%  Tween-20 
Frozen in 50mls aliquots. The levamisole, which inhibits endogenous alkaline 
phosphatases, is stable in solution for only a limited time so added fresh when 
defrosted. 
1M Tris-HCL (pH 9.5) 
12.1g  Tris in 100mls 
Bleach 
6ml  H20 
3.33ml  30% H2O2 
0.5ml  Formamide (molecular grade) 
0.25ml  20XSSC 
Mowiol: 
2.4g  Mowiol 4-88 (Polyvinylalcohol 4-88) 
6.0g  Glycerol 
mix well 
6.0ml  H20 
Leave at room temperature for 2 hours 
12ml  0.2M Tris-HCL (pH 8.5) 
Incubate at 50°C for 10 minutes and mix further. Incubate at 50°C overnight until 
dissolved. Centrifuge at 5000rpm for 15minutes, collect and store supernatant at -
20°C. 
LB Media: 
4g   Tryptone 
4g  NaCl 
2g  Yeast Extract 
400ml  dH2O 
autoclaved, cooled to ~50°C and 1µg/ml ampicillin added.  
LB agar plates: 
1.5% Agar was added to above LB and Autoclaved. Agar was cooled and poured into 














3 CHEMICAL SCREEN PART 1: Temporal perturbations 




3.1 Summary  
 
The aim of the following two chapters is to identify pathways involved in the 
development of neural crest derived tissues, focusing on craniofacial structures.  The 
morphogenesis of the head requires three-dimensional coordination of different 
tissues such as cartilage, bone, muscle and nerves. As this process is impossible to 
study in isolated cells, I used an in vivo Xenopus laevis screen to identify signaling 
pathways controlling development of these structures. I designed a small pilot 
screen where tadpoles were cultured in media containing small molecules. I chose a 
set of compounds with known biological activity, including drugs that act on 
canonical Wnt signaling, non canonical Wnt signaling, hedgehog signaling and FGF. 
By applying drugs at different stages of development I was able to perturb signaling 
during very specific developmental processes, uncovering previously unknown 




3.2.1 Biological screens  
 
“Screening” has long been used to identify what certain molecules can do and what 
processes specific pathways regulate.  Historically, the most common types of 
screens in developmental biology have been chemical screens, expression cloning 
(overexpression of protein in cells as an activity assay) or genetic screens.  
 
In classic work using Drosophila, forward genetic screens (when a mutagenised 
parent is created and subsequent generations are interbred to identify random 
mutations) have been used extensively to isolate developmentally important genes 
(Nüsslein-Volhard and Wieschaus, 1980). Genetic screens like these have been 
incredibly successful in identifying key genes and building understanding of gene 
networks in development. However, there are limitations. Identification of the gene 
that has been mutated can be very labour intensive and costly, inhibiting its 
extensive use in higher organisms such as vertebrates. More recently, technological 
advances in genome wide sequencing has allowed ENU generated mouse mutants to 
be screened with great effect (Hrabé de Angelis et al., 2000; Nolan et al., 2000) 
(Anderson, 2000).  While these mutants have contributed much to our 
understanding of development and disease, they are hampered by the irreversible 
nature of the mutations. Many pathways are used and reused throughout 
development and mutations in those pathways may present a phenotype at the 
earliest use of that gene.  Study of the later requirements may be difficult if early 
phenotypes mask the later requirements or if the mutation causes early lethality. 
 
Expression cloning screens have been successfully used to identify kinase substrates 
(Stukenberg et al., 1997), pathway components (Andrésson and Ruderman, 1998) 
and novel developmentally active molecules (Smith and Harland, 1992).  Screens 
such as these can be used to identify single proteins from a vast pool, allowing rapid 
identification of active molecules (McCormick, 1987). Expression screens are often 
performed in Xenopus or zebrafish by overexpressing pools of mRNA. This provides 
insight into what a protein can do rather than what it does in vivo. However, once a 
molecule of interest has been identified, lower levels of the protein, dominant 
negative mutants and inhibitors can be injected to study the in vivo function.  
 
Chemical screens have been used in drug discovery to detect activity of chemicals for 
over 40 years.  Application of chemicals to the assay medium of choice (proteins, 
cells, embryos etc) allow for a large number of compounds to be tested for activity in 
a rapid, controlled and reproducible manner. These chemical screens can be 
performed using libraries of compounds that may share predicted activity (such as 
kinase inhibitors) or a common origin (natural products or variations of a single 
molecular backbone). In developmental biology, this type of screen has been used to 
rapidly assay phenotypic changes in the presence of various small molecules 
(reviewed in (Wheeler and Brändli, 2009)).  When combined with an externally 
developing aquatic animal such as zebrafish or Xenopus, this technique can be 
applied at any stage in their development, allowing us to assess temporal 
requirements of a pathway.   Xenopus and zebrafish possess similar advantages in 
their application to such screens and both have proven highly useful in numerous 
previous chemical screens. However Xenopus has a significantly longer shared 
evolutionary history with mammals than zebrafish (approximately 100 million 
years) and have many similarities in both organ development and physiology 
(Wheeler and Brändli, 2009). 
 
Chemical screens themselves have limitations. Off-target drug interactions can lead 
to non-specific phenotypes and should be overlooked. Such phenotypes are not due 
to perturbation of the pathway of interest and can be misleading when interpreting 
results. However, it is often possible to address this by using more than one 
compound that perturbs the pathway in a similar manner. These compounds may 
act at a different point in the pathway or in different way to inhibit or activate the 
pathway. In this way it is possible to confirm the phenotype is due to the predicted 
effect of the drug, not due to some unknown and usually unidentifiable off target 
effect. Where this isn’t possible, perhaps because there are no other small molecules 
available, further confirmation of the phenotype can be done in later analysis using 
other well-developed molecular techniques such as injection of morpholino 
oligonucleotides (MOs) to inhibit specific protein synthesis. MOs (discussed in 
greater detail in Chapter 6) inhibit the synthesis of individual proteins and need to 
be injected or otherwise transfected into the animal. As such they are not as well 
suited for large-scale screens but can be used in conjunction with a small molecule 
screen to great effect.  
 
It is also important to recognise that the pharmacokinetics of drugs in media used to 
culture Xenopus embryos is typically unknown. The half-life of the small molecule, 
its stability at temperatures in which the embryo is viable, the ability of the drug to 
be absorbed into the embryo, as well as the metabolism of the drug will all impact 
the results of the screen.  Despite these limitations, chemical screens provide 
extremely powerful ways to identify compounds that have bioactivity and to address 
their role in multiple organ, tissue or cell development. A recent example 
demonstrates the use of a small-scale chemical screen to assess activity of 
compounds believed to perturb TGF-β signaling. Novel effects of pyridines were 
identified along with confirmation that these compounds have strong bioactivity 
(Dush et al., 2011). Our screen is similar and assesses phenotypic changes resulting 
from incubation in the presence of the small molecules at specific time points in 




3.3 Results  
3.3.1 Development of a small molecule screen to identify pathways 
involved in neural crest development  
 
In this project, I devised a small-scale screen using a number of compounds that 
would affect pathways we knew to be important in development, including 
epidermal growth factor (EGF), calcineurin, fibroblast growth factor (FGF), 
canonical and non-canonical Wnt and Hedgehog (see table 3.1: Chemicals). By 
selecting targets in pathways that are used repeatedly in development (e.g. Wnt and 
Hedgehog) I aim to highlight how a small screen could be used to identify novel 
requirements. Additionally I used two compounds with unknown targets and 
intended to determine if any insights into their mechanism could be elucidated by 
the phenotypes they induced. One has been suggested to inhibit Wnt signaling 
(pyrimidine) (Liu et al., 2005).  The second is the anti-malaria drug artestunate; its 
mode of action is unknown (MIMS, Monthly Index of Medical Specialities).  If this 
project was successful I anticipated that such a screen could be scaled up, using 
Xenopus as a model for craniofacial or neural crest development.  
 
This screen was conducted in two parts.  I performed an initial primary screen where 
embryos were incubated from the 2-cell stage in two concentrations of drug. The aim 
here was to identify which compounds caused phenotypes and to select the most 
effective concentration.  When the appropriate compounds and concentrations were 
identified I performed a secondary screen with drug additions at later stages, chosen 
to address the requirement of that target molecule during specific stages in neural 
crest development. These stages were described in more detail in the introduction.  
Neural crest induction begins prior to stage 12.5 with slug expression evident from 
stage 9 (Nieto et al., 1994). By stage 19 the NCCs are undergoing EMT and beginning 
to migrate from the dorsal neural tube.  At stage 26 the first of these cells have 
reached their destinations and early steps in differentiation are under way.  By stage 






3.3.2 Setting up the screen and identifying early phenotypes: 
 
In our pilot study, I set out to test 15 chemicals acting in signaling pathways known 
to be important in early development (Table 3.1).  Initially, embryos were treated 
with two doses of each compound, applied from the 2-cell stage onwards (schematic 
in Figure 3.1A).  The embryos were cultured in multi-well plates so overall health, 
developmental progression and morphological changes were readily assessed in live 
animals.  Animals were grown to feeding tadpole stages (stage 45, Figure 3.1B-C).  At 
this point, tadpoles were assessed for effects on the gut, eyes and overall morphology 
(Figure 3.1B-C and Table 3.2).  Changes to musculature were assessed by 
immunohistochemistry (schematic, Figure 3.1C), and some tadpoles were then 
processed for cartilage staining, marked by alcian blue (Figure 3.1C).  The primary 
screen highlighted the large variety of phenotypes that could be identified using 
Xenopus as a model; these phenotypes are outlined in table 3.2.   
 
In order to refine the temporal requirements, I performed a secondary screen where 
drugs were applied at specific time points during neural crest development.  The 
stages chosen were: stage 12.5, after induction of neural crest; stage 19, during early 
migration of the neural crest and at two stages of differentiation, stage 27 and stage 
37 (schematic in Figure 1A).  At stage 27, the neural crest has migrated into the facial 
mesenchyme and by stage 37 chondrogenic condensations become apparent.  
Compounds were washed out at the end of the treatment stage and embryos were 
transferred to new multiwell plates in fresh, untreated media. However, we did not 

















3.3.3 Early perturbations result in axis truncations 
 
It was strikingly apparent that drug treatments resulted in very severe defects in the 
elongation of the tadpole. This phenotype was only seen when the embryos were 
treated early.  Anterior-posterior (A-P) determination occurs very early in Xenopus 
embryos, during gastrulation (Slack and Tannahill, 1992) (Lane and Sheets, 2000), 
but in the majority of the shortened tadpoles there appeared to be a reduction in the 
number of somites, rather than any perturbation in initial A-P patterning. The 
exception was in the 2-cell BIO treated tadpole where there were dramatic 
perturbations in anterior structures (discussed chapter 6) (Figure 3.2D).  
 
Dramatically shortened tadpoles were seen in either 2-cell treatments (Figure 3.2C, D 
and G) or those incubated in drug between stages 12.5 and 19 (Figure 3.2E&H).  
Fibroblast growth factor (FGF) inhibition, using SU5402, at the 2-cell stage truncated 
the posterior extension of the tadpole while the face remained unaffected (Figure 
3.2C). In embryos treated during the same period with the hedgehog agonist 
purmorphamine the body axis was similarly shortened (Figure 3.2G). GSK-3 
inhibition using BIO and up regulation of hedgehog with purmorphamine during 
stages 12.5-19 resulted in a somewhat less severe truncation than the 2-cell but some 
reduction in the length of the tail was seen. In the stage 19+ treatments no elongation 
defects were scored (Figure 3.2F & E).  Changes in the somites can also lead to 
truncations. Somite development is perturbed in the embryos exposed to SU5402, 
BIO and purmorphamine from 2-cell (Figure 3.2C, D and G). The more anterior 
somites lack the correct chevron shape (schematised in the tail, Figure 3.2A) and are 
thicker than those in the WT (Figure 3.2B). Those towards the posterior of the tail are 
prematurely very thin.   

 3.3.3.1 Two compounds altered the height of the neural crest derived tailfin 
 
The tailfin is made up of neural crest cells that migrate out of the neural tube towards 
the posterior (Collazo et al., 1993). Two drug treatments, IWR and cyclosporin, were 
found to change the size of tail fin when scored in stage 45 tadpoles.  Inhibition of Wnt 
signaling using Inhibitor of Wnt Receptor (IWR) from the 2-cell stage throughout 
development resulted in a dramatic loss of tailfin above and below the body (Figure 
3.3C) compared to WT (Figure 3.3A-B).  When drug was applied at stage 12.5 and a 
washout performed at stage 19 a similarly severe phenotype was observed (Figure 3.3E).  
The dorsal-ventral extent of the tailfin in both these treatments was 0.5x that of the WT 
(all measurements were taken a uniform distance from the tail tip, site shown in 
yellow).  However, this phenotype was not found in later treatments (stages 19-37, 
Figure 3.3G and stage 37-45, Figure 3.3I).  Consistent with roles for Wnt, early IWR 
treatment may be causing a global reduction in neural crest derived tissues (discussed 
in Figure 4.3).  In the later treatments these phenotypes are less severe (see almost 
phenotypically normal tadpole when treated at stage 37, Figure 3.3I).   
 
Cyclosporin treatment resulted in a marginal but measurable thickening of the dorsal 
tailfin  (Note, measurements, shown in red, were taken above the proctodeum (Figure 
















3.3.4 Melanocytes are dramatically altered.    
 
The melanocytes arise in the dorsal neural tube and migrate as unpigmented cells to 
populate many organs before differentiating into pigmented, mature melanocytes 
(Douarin, 1999). These cells are specific type of chromatophore that possess specialized 
vesicles called melanosomes which contain eumelanin, a type of melanin that appears 
black or brown (Wasmeier et al., 2008). In the developing embryo, melanocytes are 
often variable in both size and number, even within tadpoles from the same clutch. 
Some striking phenotypes were observed but it should be noted that I did not 
differentiate between a loss of melanocytes and a loss of melanosomes. Nor did I look to 
see whether the melanocyte cell shape itself was changed or whether the lack of a 
starred shape was caused by changes to diffusion of melanosomes in the cell.  
 
Figure 3.4 shows close up images of the melanocytes in embryos from a number of 
treatments. Two treatments resulted in melanocytes that appeared smaller and more 
rounded (BIO, Figure 3.4B and purmorphamine, Figure 3.4E), while tadpoles treated 
with the Hedgehog inhibitor cyclopamine showed an absence of melanocytes (Figure 
3.3D). In contrast, cyclosporin treatment caused an increase in the number of trunk-
derived melanocytes seen in both the cranial and caudal regions of the tadpole (Figure 
3.4C).  
 
Both the cyclopamine and BIO phenotypes were stronger in response to continuous 
treatment; in contrast, cyclosporin was effective in all treatments (Figure 3.5B-C and F-
G). These tadpoles showed excessive melanocytes delaminating in huge numbers from 














3.4 Discussion & Conclusions  
 
A large number of morphological phenotypes were identified in this chemical screen, 
some novel and some well characterized. Perturbations during early stages, such as 
many of those described here, can be used to complement other approaches, such as 
mRNA overexpression or knockdown of gene activity by antisense morpholino 
oligonucleotide (MO) injection. Treatment at these stages can be used to rapidly identify 
molecules that have activity in the embryo and in some cases can be used to test 
pathway specificity.  
 
3.4.1 Well characterized phenotypes can be identified and confirmed rapidly 
 
One of the first developmental processes to be explored in detail in Xenopus was A-P 
patterning. There are a number of pathways known to be crucial for proper extension of 
the embryo (Lane and Sheets, 2000) (Slack and Tannahill, 1992). FGF signaling is one 
such pathway; therefore, the stunted tadpoles (Figure 3.2C) were unsurprising.  
However, in later stages FGF is thought to be required for patterning of craniofacial 
structures (Bachler and Neubüser, 2001) (Johnston and Bronsky, 1995) (Nie et al., 
2006) (Szabo-Rogers et al., 2008) so it was surprising that the 2-cell treatment did not 
affect the development of the anterior structures or face. In these experiments, 
compounds were added at the 2-cell stage, with no reapplication. It is possible that the 
activity of the drug has diminished before patterning the face.  In the future treatment 
at later time points may give hints to both the requirements of FGF signaling in the 
head and to the in vivo pharmacokinetics and pharmacodynamics of SU5402.   
 
3.4.2 Interesting changes to the melanocytes suggest more than one 
mechanism has been altered 
 
Inhibition of hedgehog signaling during early development causes a dramatic loss of 
NCC (Brito et al., 2006). I hypothesize that the severe loss of melanocytes, along with 
the obvious changes to the cranial structures in the embryos treated from 2 cell and 
stages 12.5 with cyclopamine derive from an increase in apoptosis of neural crest cells 
due to lack of caudal endoderm sonic signaling (Figure 3.5C-D) (Ahlgren and Bronner-
Fraser, 1999). BIO had a similarly severe early phenotype though the presence of more 
craniofacial tissue when compared to cyclopamine treated suggested a different 
mechanism affecting the melanocytes.  
 
Cyclosporin A treatment had an interesting effect on melanocyte proliferation 
(Figure.3.5F-I). Actually, regulation of calcineurin activity is used in a variety of human 
treatments for pigmentation disorders.  Vitiligo is caused by the production of 
antibodies against the patient’s own melanin.  This autoimmune disorder results in 
white patches of skin due to the destruction of melanin.  It can be treated with topical 
application of calcineurin inhibitors that act to inhibit the immune system (Leitner et 
al., 2011) (Gawkrodger et al., 2010).  Another role for the drug-induced suppression of 
calcineurin in the immune system is in prevention of transplant rejection.  Various 
calcineurin inhibitors including cyclosporin A have been used in transplant therapy 
(Taïeb, 2005).   However, this treatment can be a double-edged sword as calcineurin 
inhibition can also induce melanoma in organ transplant recipients (Walsh et al., 2011). 
Furthermore, calcineurin may play a role in delamination and some data suggest that 
calcineurin inhibition by cyclosporin A is responsible for nephrotoxicity in transplant 
recipients (Slattery et al., 2005). Collectively these data suggest that the hyper 
pigmentation seen in the cyclosporin treated tadpoles may be due to either an increase 
in melanin production in the developing melanocytes or due to an increase in the 
number of neural crest cells delaminating from the neuroepithelium. 
 
This assay has shown that studying the various stages in neural crest development can 
be done rapidly and with ease.  Important signaling pathways in the development of 
your favourite structure can be readily assigned a temporal window that, in the case of 
the phenotypes that may mimic one of the many neurocristopathies, can allude to the 
developmental process affected. Our data demonstrate a straightforward method to 
examine the development of organ systems and tissues that are developing 
concurrently, important in pleiotropic syndromes. Future studies can incorporate other 
molecular approaches such as transgenic techniques. Traditional protein studies are 
well established in Xenopus.  Combined with drug assays this provides potential for 
rapid validation of drug-protein interactions with the added bonus of in vivo vertebrate 
biology.    




4.1 Introduction  
 
This chapter will focus on the more novel phenotypes that I encountered in the chemical 
screen, with an in-depth focus on modulators of the Wnt and Hedgehog pathways.  
These include changes to the eye, craniofacial structures and to the guts.  We know that 
NC contributions are crucial for eye and facial formation.  In addition, the gut was 
highlighted as it displayed phenotypes with numerous clear temporal implications in 
signaling, highlighting one of the strengths of this screen.   
 
In Xenopus the neural crest migrates in three streams which give rise to distinct 
portions of the craniofacial cartilage, the branchial stream (which splits into two), the 
hyoid stream and the mandibular stream. The mandibular stream is Hox-negative and 
comes from rostral rhombencephalic and mesencephalic region of the brain.  It 
migrates into the first arch before differentiating into the lower and upper jaw cartilages 
(Meckel’s and the palatoquadrate respectively).  A small number of cells from this 
anterior stream contribute to the posterior region of the palatoquadrate.  The Hox-
positive streams are the more posterior, originating from rhombomeres 4 to 7. These 
streams colonise the second, third, and fourth arches where they give rise to the hyoid 
skeleton (Sadaghiani and Thiébaud, 1987) (Baltzinger et al., 2005).  
 
Though much of the early work to identify the tissues that receive neural crest 
contribution was done in chick, Xenopus has a well-characterised cell lineage.  Not only 
has lineage tracing been used to follow the development of each cell in the 32/64 cell 
embryo through development, allowing specific targeting to tissues in the later tadpole, 
but the contributions of each neural crest stream to the face are known (Sadaghiani and 
Thiébaud, 1987) (Baltzinger et al., 2005).  This allows us to determine from the changes 
in the face which of the neural crest streams have been most severely affected.  
 
The contribution of the neural crest to the eyes is less clear-cut but the mesenchymal 
and choroid layers, along with the cornea of the eye are derived from the mandibular 
crest stream (Nagy et al., 2006) (Sadaghiani and Thiébaud, 1987).  Neural crest cells not 
only contribute to the structures of the eye but may also be important in patterning 
their development (Grocott et al., 2011).  
 
Neural crest cells colonize the developing gut in a rostro-caudal wave after entering the 
foregut following migration from the neural tube (Burns and Douarin, 1998) (Nagy et 
al., 2006). Here, they differentiate into the neurons of the enteric nervous system. It is 
clear that failure of this tissue to migrate correctly (described in Xenopus (Collazo et al., 
1993)) results in defects in later gut development and is implicated in a number of 
human birth defects, including Hirshsprung’s (Epperlein et al., 1990) (Tobin et al., 
2008b). Although I have not scored for any potential changes in the innervations of the 
gut, I describe the phenotypes found in the gut as an interesting illustration of temporal 





















4.2.1 Midline defects were associated with close-set eyes in early 
treatments  
 
By stage 45 the eyes are mobile and set wide on either side of the face.  They have 
obvious lenses and darkly pigmented retinal epithelia.  Many of the compounds caused 
defects in eye development, ranging from alterations to size and positioning to 
micropthalmia and cyclopia.  Some of these defects were associated with midline defects 
that changed the positioning of the eyes, discussed in Figure 4.1.  
 
I found that in a number of these treatments, phenotypes decreased in severity with 
later additions of the compounds.  This was most evident with GSK-3 inhibition using 
BIO where the 2-cell stage resulted in a cyclopic embryo (yellow star, Figure 4.1E). In 
the stage 12.5 – 19 treatment two eyes were obvious, even though they remained very 
close to the brain (green arrow, Figure 4.1F).  By the stage 19-37 treatments tadpoles 
looked normal (Figure 4.1G). Hh inhibition using cyclopamine causes a dramatic 
narrowing of the midline in the 2-cell, stage 12.5-19 and stage 19-37 treatments (green 
arrow, Figure 4.1B-D) though the midline was less dramatically decreased in the latter 
treatment.  In the first two treatments the eyes remained close to the brain. By stage 19 I 
saw proper separation of the eyes away from the midline. IWR treatment also causes a 
severe midline defect in the 2-cell treatment (green arrow, Figure 4.1H) and, like in 
cyclopamine treatment, this resulted in eyes that remain close to the brain.  When 
applied between stages 12.5-19 the phenotype looks remarkably similar with the same 
close-set eyes.  With application during stages 19-37 the severity decreases (Figure 4.1I-
J).   
 
Along with changes in the positioning of the eyes (presence/absence of eyes and 
proximity to the brain) some morphological changes were identified. The early up 
regulation of Hedgehog signaling with purmorphamine causes poorly patterned 
pigmented retinal epithelia along with a narrowed midline (as discussed above & Figure 
4.1) but the compact, pigmented nature of the eyes when embryos were incubated 
between stages 12.5-19 treatments were unaffected.  In later treatments this 
disorganised retina does not occur (Figure 4.1K-M).   
 
Wnt inhibition also caused lens defects in the two earlier exposures.  There is severe 
edema in IWR treated tadpoles and the swelling pulls the lens from the eyes as they are 
attached to the skin (red arrow, Figure 4.1H-J).  Rho/Rac inhibition shows a similar 
lens defect the same two treatments (red arrow, Figure 4.1N-P) along with 


























4.2.2 A closer look at the changes to the eyes 
 
In order to further assess the changes to the eye, I examined coronal sections of treated 
tadpoles (Figure 4.2).  Sections through BIO-treated tadpoles at stage 45 show a 
cyclopic eye (arrowhead) below the brain (arrow) (Figure 4.2C) with little other tissue 
seen in the anterior of those embryos.  When treated with the Wnt inhibitor, IWR, 
tadpoles have narrowed midlines with eyes that are relatively well patterned.  The 
lenses appear to have failed to detach from the overlying epithelium and as the edema 
distorts the skin the lens is pulled from the attached eye (Figure 4.2D). Finally, in two 
other conditions with narrowed midlines, the eyes remain close to the brain 
(cyclopamine and purmorphamine, Figure 4.2E - 4.2F).  In cyclopamine treatments the 
eyes appear close-set but appropriately patterned with the lens, ganglion cell layer, 
nuclear cell layer and pigmented retinal epithelium obvious (Figure 4.2E).  In contrast, 
over activation of hedgehog signaling by purmorphamine treatment strongly affects eye 
formation, resulting in disorganised structures that remain contiguous with the brain 





















4.2.3 Hedgehog and Wnt are important in craniofacial cartilages 
 
To confirm Wnt and Hh effects on craniofacial cartilage I stained the stage 45 tadpoles 
with Alcian blue, which binds to acidic mucopolysaccharides and glycosaminoglycans in 
cartilage (Figure 4.3).  These cartilages develop from neural crest, which emerge from 
the neural tube to populate the developing face (schematic Figure 4.3A-C).  Because 
affected cartilages suggested that defects in subsets of neural crest streams might 
correlate with loss of specific facial cartilages, I decided to examine the NC during 
migratory stages using twist expression. 
 
Activation of Wnt by BIO resulted in a strong reduction in anterior cartilages (Figure 
4.3E-J).  Affected tissues included Meckel’s cartilage, the parahyoid and anterior 
ethmoid plate; however, the gill cartilages were relatively unperturbed (Figure 4.3E-J).  
This suggested that the anterior-most streams (schematised in red and yellow, Figure 
4.3A-C) are the most sensitive to changes in GSK-3 activity.  Indeed, in situ 
hybridisation for twist mRNA revealed dramatic loss of these tissues (Figure 4.3O).  
 
In contrast, I found that Wnt inhibition by IWR resulted in cartilages that appeared 
reasonably well patterned.  However, upon dissection, I found them to be less 
structurally solid than their control counterparts (note less intense staining in the 
parahyoid, Figure 4.3F-K).  The infrarostral cartilage is absent in the IWR treated 
tadpoles (see Figure 4.3C) but Meckel’s cartilage appears normal (Figure 4.3K).  
Consistent with these observations, I found that streams of twist positive cells were not 
as well defined; however, the amount of twist positive tissues does not appear reduced 
(Figure 4.3P). 
 
Inhibition of Hedgehog by cyclopamine treatment caused the most catastrophic loss of 
cranial cartilages, leaving only a remnant of the posterior parahyoid and the otic 
capsules (Figure 4.3G-L).  When I examined twist expression, I found some loss of 
posterior neural crest streams; however, the neural crest flanking the eye appears to be 
migrating along the appropriate path (yellow, Figure 4.3A and 4.3Q).  These data 
suggest that Hedgehog signaling may not be required during migration and may play 
additional roles in the neural crest, including survival (Brito et al., 2006) (Ahlgren and 
Bronner-Fraser, 1999).    
 However, when Hedgehog signaling is activated by purmorphamine, the cartilages are 
largely unaffected.  The infrarostral cartilage is lost though this may be due to the 
widened midline, discussed below  (Figure 4.3H-M).  Neural crest migration appears 
































 4.2.4 Some of the phenotypes were subtle  
 
In three of the drug incubations I noticed that the infrarostral cartilage was absent 
despite an apparent overall normal patterning of the cartilage. In three cases, there was 
no midline defect, in contrast to purmorphamine treatments discussed above.  
Alsterpaullone (Figure 4.4B) and pyrimidine (Figure 4.4D) caused no other apparent 
phenotypes so it came as a surprise to see such a specific absence of cartilage.  It was 















 4.2.5 The craniofacial muscles are also affected  
 
As described above, craniofacial cartilages are strongly affected by perturbation of Wnt 
and Hh signaling. Given the intimately linked nature of the cartilages and craniofacial 
muscles, I decided to examine changes to the presence and positioning of these muscles.  
 
I looked for changes by immunohistochemistry using an antibody that recognises 
skeletal muscle (Figure 4.5/4.6). A schematic of the anatomy and WT tadpoles show the 
normal musculature (4.5A-C’).  Drug treated tadpoles are examined in Figure 4.6. In the 
BIO treated tadpoles, changes to the head muscles correlate with the anterior cartilage 
defects described above. Unsurprisingly, given the cyclopic nature of the tadpoles, the 
optic muscle complex is severely affected (red arrowhead, Figure 4.6B). The levator 
mandibulae complex is not apparent. Extension of the muscles in the truncated 
mandibular region is shorter: note the intermandibularis posterior, interhyoideus and 
constrictor branchialis complex (yellow arrow, yellow arrow head and blue arrowhead 
respectively, Figure 4.5M). In IWR treatment the majority of muscles are decreased in 
size, with the abdominal muscles most severely affected (red arrowhead, Figure4.6H). 
The hyoangularis and intermandibularis muscles are also much shorter. Thus, 
activation of Wnt signaling results in concurrent changes in facial cartilage and muscle, 
while inhibition has minimal effects. 
 
Inhibition of Hedghog signaling results in a striking loss of head muscles. The majority 
of the dorsal muscles are absent, with only the interhyoideus and a diminished 
orbitohyoideus remaining (Figure 4.5O). On the contrary, the axial muscles are largely 
normal (note the abdominal muscles in Figure 4.5I and the somites in Figure 4.5N). 
Purmorphamine treatment does not result in the loss of any of the craniofacial muscles. 
However, the interhyoideus muscle is discontinuous at the midline (red arrowhead, 








4.2.6 Early perturbations most strongly affect gut development 
 
In tadpoles, the gut develops stereotypically (Nieuwkoop, 1994).  By stage 45, the tightly 
coiled gut is easily visible (WT 4.7A) but little is known about the signaling mechanisms 
required for correct patterning in the development of the visceral mesoderm.  The 
coiling of the gut was affected in numerous drug treatments.  Several manipulations led 
to an absence of gut coiling, loss of gut coiling, delayed gut coiling or gut elongation 
phenotypes.  The wide variety of phenotypes and the large number of compounds that 
affected development suggest that the complex process of gut development was affected 
at different stages in these treatments and that different processes have been altered.   
 
Typical development of the gut begins very early. This screen has not examined changes 
in the patterning of the endoderm in the early development (Chalmers and Slack, 2000) 
nor have we looked at the possibility that treatments were perturbing left right 
symmetry in the embryos (Dush et al., 2011). Instead, I have focused on whether the 
intestinal tubes coiled (described in detail by (Nieuwkoop, 1994)).   
 
Initial treatment with three of our compounds resulted in very dramatic elongated gut 
phenotypes: IWR (Figure 4.7F-I), cyclopamine (Figure 4.7B-E) and rockout (Figure 
4.7J-M).  For cyclopamine and IWR, these phenotypes were also evident in the refined 
treatments (stage 12.5 – 19, Figure 4.7C & G). In these phenotypes it appears that the 
gut tissue has extended along the elongating body axis without any attempted 
independent coiling and maturation (Figure 4.7B-C & 4.3F) (Chalmers and Slack, 
2000).   This trend continued in the latter two treatments (Figure 4.7L-M).  IWR 
application at stage 19 resulted in an attempted at gut coiling. However, stage 37 
treatments were largely benign (Figure 4.7E).  In contrast, by stage 12.5-19, inhibition of 
Rho kinase by Rockout only caused a delay: though the guts were coiled, they appeared 
more like that of stage 43 tadpoles (Figure 4.7K).   
 
Not all the treatments caused elongated phenotypes. In cyclosporin treatment guts have 
very little differentiated tissue in the abdomen.  This phenotype results from all stages 
of treatment (Figure 4.7N-Q).  Purmorphamine has yet another type of gut phenotype.  
Hedgehog agonism causes a gut that is appropriately positioned yet the coiling is 
disorganised (Figure 4.7R-T). This phenotype was present in all the treatment windows 
































4.2.7 Wnt signaling is required throughout development of the gut.   
 
I chose to look more closely at the effects that both the edema and the delayed coiling of 
the gut (discussed in previous figure) have on the proper differentiation of abdominal 
structures and muscles (Chalmers and Slack, 2000).  As described above, I found the 
progressively less severe phenotype in later treatments suggests that Wnt signaling is 
most important during initial stages of gut development.  Treatment of 2-cell embryos 
caused severe edema and an extended and predominately undifferentiated gut, clearly 
seen in sections through the gut (Figure 4.8G&L).  Addition of compound at stage 12.5 
resulted in an extended, uncoiled gut similar to that from the 2-cell treatment (Figure 
4.8C).  However, when I sectioned these animals, I found that the later treatment 
resulted in increasingly differentiated tissues within the intestines (Figure 4.8H).  
Treatments beginning at stage 19 still resulted in poorly patterned guts but some coiling 
was evident, while the edema is much reduced (Figure 4.8D&I).  By stage 27, treated 
guts appeared delayed, rather than disrupted; tissue complexity in the abdomen was 
almost WT (Figure 4.8E&J).   
 
Concurrently, I examined the body wall muscles.  The abdominal muscles begin to 
develop at stage 31 when undifferentiated cells coalesce from the trunk myotomes.  
These cell clumps migrate beneath the epidermis and at stage 39 begin to broaden into 
sheets of muscle that extends from the pericardium to the proctodeum (Lynch, 1990).   
The trunk myotomes appear disorganised in the IWR treatment so it may be that this 
disorganisation has delayed or perturbed the ventral migration of the cells that will 
become the body wall muscles (Martin and Harland, 2001).  The rectus abdominal 
muscle lies along the lateral side of the gut in stage 45 tadpoles as a tightly associated 
sheath (arrow, Figure 4.8K). In IWR-1-endo treatment, along with changes to gut 
coiling I see disruption in this sheath of muscle (Figure 4.8BL-O).  I found diffuse 
abdominal muscles in severely affected tadpoles; these animals were also edematous.  
(Figure 4.8L-O).  Later additions of IWR-1-endo resulted in nearly normal muscles 





4.3 Discussion and Conclusions  
 
 
This chapter has demonstrated that a large number of phenotypes can be assessed in a 
rapid and reproducible manner using Xenopus as a model for craniofacial and neural 
crest development. By applying small molecules to the embryos at discrete time points I 
was able to determine temporal requirements for various signaling pathways in the 
development of numerous organs. Though this screen was aimed at developmental 
stages that were important to neural crest development, such a screen could be adapted 
to study any process of interest.   
 
When we examined the tadpoles treated at various stages for changes to the head shape 
and to the eyes it was apparent that the most severe changes occurred with the early 
perturbations. In order for a tadpole to develop a true cyclopic phenotype the induction 
of the prechordal plate of the division of the forebrain must be affected.  It has been well 
established in chickens and in Xenopus that Shh is a key regulator in the division of the 
eye field (Li et al., 1997) (Pera and Kessel, 1997) though in Xenopus is it suggested that 
Shh signaling is not required for the correct specification of the floor plate (Peyrot et al., 
2011).  As only the embryos treated with BIO at two cell stage developed true cyclopic 
phenotypes, I would postulate that this region is likely unaffected in the cyclopamine 
treated tadpoles, as the eye field retains its division (Chow and Lang, 2001). The BIO 
phenotype will be further addressed in chapter 4.  
 
Many of the eye phenotypes scored in the drug tadpoles could be attributed to changes 
to the midline.  The most interesting change to the eyes came with the overactivation of 
Hedgehog using purmorphamine, where I saw changes to the layers of the eye and a 
loss of compact pigmented epithelial retina.  This correlates with studies in zebrafish 
which have shown that Hedgehog signaling is required for the dorsal-ventral patterning 
of the eye and that overactivation of Hh signaling results in a loss of dorsal retinal 




There were dramatic changes to the craniofacial cartilages and I have shown that 
apparently similar phenotypes can be readily attributed to distinct developmental 
processes.  For example, changes to cranial structures may arise because of defects in 
neural crest migration (BIO, discussed chapter 5), potential defects in tissue survival 
(cyclopamine) or changes to underlying morphology (midline expansion, 
purmorphamine).  However, the loss of the infrarostral cartilage was an interesting and 
subtle phenotype that came as a surprise. To the best of my knowledge this small 
cartilage is derived in the same manner as Meckel’s cartilage.  In fact, in salamanders or 
newts, it has been proposed that the infrarostral cartilage is a specialised anterior part 
of Meckel’s (Svensson and Haas, 2005). The Xenopus bagpipe ortholog zampogna is 
expressed in the mesenchymal cells of the future infrarostral cartilage so it would be 
interesting to see if expression of this gene is altered in IWR and other treatments.  This 
would suggest that the infrarostral cartilage is regulated and develops in a manner 
independent of Meckel’s cartilage.      
 
Assays of this nature can reveal links between seemingly disparate phenotypes such as 
loss of muscle and cartilage.  Conversely, phenotypes that appear obviously linked, such 
as deformed gut and abdominal muscle, may be uncoupled.  While Wnt signaling is 
clearly required throughout the coiling of the gut it is also needed for proper 
development of the abdominal muscles (Martin and Harland, 2001). Furthermore, if the 
epidermal layer is disrupted due to structural changes or pressure from edema then the 
muscle precursor aggregates may be unable to migrate to the correct position. Given the 
relatively late development of this muscle sheet I would postulate that the severely 
malformed muscles in early treated tadpoles are closely associated with the observed 
edema.  
 
The majority of the phenotypes were found most commonly or to be more severe in the 
2-cell stage treatments, suggesting that the drugs are acting on early embryonic 
processes. In particular, changes to the gut may be due to a loss of left-right patterning 
that renders the embryo incapable of looping the elongating gut. Should this need to be 
addressed in more detail, the expression pattern of genes that are expressed in an 
asymmetric L-R pattern, such as nodal, could be examined (Dush et al., 2011).  
 
5 HEDGEHOG SIGNALING DETERMINES THE SIZE OF 
THE PRIMARY MOUTH  
 
5.1 Summary  
 
One interesting and unexpected phenotype that came out of the chemical screen was the 
effect that Hedgehog (Hh) perturbations had on the size of the primary mouth. I found 
that inhibition of Hedgehog signaling resulted in a reduced or imperforated mouth 
while increasing of hedgehog signaling dramatically increases the size of the mouth.  
 
In vertebrates, patterning of the mouth is a multi-step process requiring interactions 
between numerous tissue types. Here I define the primary mouth as the initial opening 
of the alimentary canal and the secondary mouth as the complex mouth structure 
including palette, teeth, tongue etc. Though there is some understanding of important 
steps in formation of the secondary mouth structures, less is known about molecules 
that control initiation of oral perforation. The formation of the primary mouth in a 
number of vertebrate models has been well characterised (Takahama et al., 1988) 
(Waterman, 1977) (Waterman and Schoenwolf, 1980). Development of the primary 
mouth in Xenopus has been elegantly described by recent work from Dickinson and 
Sive (Dickinson and Sive, 2006). Although Hedgehog signaling has a well-characterised 
role in the development of the vertebrate secondary mouth, nothing is known about its 
role in primary mouth development, or in regulating the perforation of the 
buccopharyngeal membrane, an essential step in primary mouth formation.  
 
In vertebrates the mouth opening forms as a result of contact between the invaginating 
stomodeal ectoderm and the underlying endoderm. In an analogous process, 
ectodermal-endodermal interactions also precede the opening of the hindgut, followed 
by dissolution of a membrane. The formation of the cloacal membrane occurs with the 
loss of mesodermal cells and basement membrane proteins separating the ectoderm 
and endoderm cells (Hassoun et al., 2010).  While there are no previous data suggesting 
that Hh has a role in the dissolution of the buccopharyngeal membrane, there are some 
indications that Hh signaling may be important in regulating formation and dissolution 
of the cloacal membrane (Mo et al., 2001) (Perriton et al., 2002) (Parkin et al., 2009) 
(Seifert et al., 2009).  Shh mutants have a persistent cloacal membrane, demonstrating 
an early role for Hedgehog in cloacal septation (Haraguchi et al., 2007).  Aberrant levels 
in Hedgehog signaling in Gli2-/- and Gli3-/- mouse mutants also lead to dorsal cloacal 
membrane persistence in a dose responsive manner (Kimmel et al., 2000) (Mo et al., 
2001). Persistence of this membrane in humans is associated with numerous anorectal 
anomalies, most common in females (Kim et al., 2001) (Levitt et al., 2011; Rosen et al., 
2002).  
 
In human patients some syndromes that present with anorectal defects have been 
identified as having mutations in the Hedgehog pathway. In the case of Pallister-Hall 
syndrome there is a mutation in Gli3 (Kang et al., 1997).  Indeed, VACTERL is used as a 
clinical diagnosis of non-random birth defects (names derives from vertebral defects 
(V), anal atresia (A), tracheoesophageal fistula with esophageal atresia (TE), radial and 
renal dysplasia (R)) and many of these have been attributed to mutations in the 
hedgehog effector genes (Doray et al., 1999; Kim et al., 2001; Topf et al., 1993).  
 
As Hedgehog signaling is known to play important roles in facial patterning and is 
expressed in the right tissues at appropriate times I hypothesized that Hh levels might 
also affect primary mouth development. To address this I used small molecules to alter 
levels of Hedgehog signaling and analyzed the tadpoles at feeding stages (stage 45).  My 
results showed that increasing the levels of Hh signaling with the Hh agonist 
purmorphamine resulted in a dramatically expanded mouth. This appears to be due to 
premature contact between the two tissue layers. Conversely, treatment with the Hh 
inhibitor cyclopamine reduced the size of the oral opening in a dose-dependent manner, 
with high doses leading to a complete loss of the mouth. In this case, there appears to be 







5.2 Results  
 
5.2.1 Levels of Hedgehog signaling determine size of the primary mouth  
 
In the primary screen outlined in chapter 3 I described the effect of Hedgehog 
manipulations on overall tadpole morphology. Consistent with previous reports, I found 
that treatment with cyclopamine (up to 250µM) resulted in tadpoles with narrower 
cranial width and shorter heads (Figure 5.1B) when compared to controls (Figure 5.1A) 
(Chen et al., 2002). Though the cyclopamine treatment led to significantly smaller 
heads, I found, to our surprise, that incubation in purmorphamine, the Hh agonist, 
resulted in broadly similar phenotypes (Figure 5.1C). To gauge the width of the head, I 
took two measurements at stage 45: between the eyes and at the widest point in the 
head (schematic, Figure 5.1D). Both measurements were important as there was often 
significant edema seen around the face that distorted the width of face. Measuring 
between the eyes gave me a representation of both the reduction in distance between 
the eyes but also of overall loss of facial growth in embryos where the eyes were still 
separate. However this distinction was not pursued.  
 
To determine the extent of facial growth, I measured the length of the face from behind 
the eyes as well as the distance from the front of the eyes to the most anterior point 
(schematic Figure 5.1E). In both treatments the tadpoles were statistically significantly 
shortened in all dimensions in comparison to EtOH, the drug vehicle control (*, Figure 
5.1D-E P<0.001). No statistically significant difference was found between the 












 5.2.2 Hedgehog regulates mouth size in a dose responsive manner 
 
One huge advantage of a drug manipulation in this manner is the ability to precisely 
regulate the dose added to the media. As such I varied the dose and tested to see if 
modulating the amounts of Hedgehog signaling resulted in a graded response in the 
size of the mouth. To do this, I applied a range of concentrations of both cyclopamine 
and purmorphamine treatments beginning at stage 2. Embryos were treated with 
250μM cyclopamine (Figure 5.2A), 50μM cyclopamine (Figure 5.2B) and 5μM 
cyclopamine (Figure 5.2C) to decrease Hedgehog signaling. To increase Hedgehog 
signaling I treated the embryos with 2μM purmorphamine (Figure 5.2E), 20μM 
purmorphamine (Figure 5.2F) and 100μM purmorphamine (Figure 5.2G). I found dose 
of drug correlated with a clear graded response in the size of the mouth (Figure 5.2).  
5.2.3 The size of the mouth is plastic until late in development  
 
The WT mouth at stage 45 is approximately the width of the nasal pits and just dorsal to 
the cement gland, (schematised in Figure 5.2M). As mentioned, early treatment with 
cyclopamine at the 2-cell stage results in a mouth that doesn’t perforate, although in 
some embryos a keyhole depression is apparent (outlined in red, Figure 5.2I). 
Treatment from stage 12.5-19 dramatically reduced the size of the mouth (Figure 5.2J), 
as did treatment from stage 19 to 37 (Figure 5.2K). Treatments at stage 37 have no effect 
on mouth width, suggesting that the requirement for hedgehog signaling on mouth size 
occurs prior to this stage (Fig 5.2L). In contrast, maintaining Hedgehog activation is 
sufficient to increase the size of the mouth. Treatment with purmorphamine from the 
two-cell stage narrows the head but hugely expands the mouth (Fig 5.2N) when 
compared to the control (Figure 5.2H). This expansion is seen in all later treatments, 
with decreasing severity (Figure 5.2 O-Q)). Unlike the stage 37-cyclopamine treatments, 
purmorphamine continues to affect the width of the mouth in the later treatment 
(Figure 5.2Q).  This suggests that while the initial development of the mouth requires 
early hedgehog signaling the mouth size can be expanded late into development by an 
increase in Hh.  
 
It should be noted that in the embryos where an expansion of the mouth was seen, the 
mouth cavity was not as greatly expanded so it is possible to see both the most exterior 
edge (red dotted line, Figure 5.2) and on occasion the inside of the mouth cavity which 
is highlighted with a yellow dotted line (Figure 5.2N-Q).  
 
Figure 5.2 Development of the mouth is sensitive to both dose and timing of hedgehog signaling.   
 
(5.2 A-C) Frontal views of tadpoles exposed to 250µM, 50µM and 5µM cyclopamine from the 2-cell stage and grown to stage 45. 
Note loss of mouth in high doses (Figure 5.2A-B) and small, perforated “keyhole” mouth (Figure 5.2C). 
(5.2D) Control vehicle treated tadpole in 0.01% EtOH control 
(5.2E-G) Frontal views of tadpoles treated with 1µM, 10µM or 100µM purmorphamine and grown to stage 45. Note increased mouth 
size with increasing concentrations of purmorphamine.  
 
(5.2H-Q) Timing of drug sensitivity.  
(5.2H) Vehicle treated control tadpole, stage 45. 
(5.2I-L) Treatment with 50µM cyclopamine at indicated stages. All treatments up to stage 37 with cyclopamine reduces the mouth 
size (5.2I-K). Treatments after stage 37 (5.2L) do not affect mouth size or perforation. 
(5.2N-Q) All treatments with 100µM purmorphamine lead to a larger mouth.  
External edge of mouth opening outlined with red dotted line; internal edge of mouth opening outlined with yellow dotted line.  
(n≥35 in all treatments). 
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5.2.4 Xenopus mouth develops in a stereotypical manner 
 
Dickinson and Sive document the normal development of the mouth, describing how 
the mesoderm between the endoderm and ectoderm is removed and the primary mouth 
opens. They report that the first obvious sign of mouth formation occurs from stage 22, 
marked by the dissolution of the basement membrane that separates the ectodermal cell 
population from the endoderm cells (Dickinson 2006). Following this the depression 
called the stomodeum can be visualized. This depression deepens as apoptosis and cell 
intermingling thin the ectoderm/endoderm tissue during mid-stage 30’s (Dickinson 
2006). By early stage 40’s this membrane has dissolved and the mouth is open. It has 
been shown that the endoderm is required not for induction of the stomodeum but for 
the perforation of the mouth opening (Dickinson and Sive, 2006). Hedgehog ligand is in 
the anterior endoderm; therefore, I hypothesized that the duration of Hh reception 
might be critical to the size of the oral opening.  
 
As outlined in Figure 5.5, contact between the endoderm and ectoderm followed by 
dissolution of the basement membrane and apoptosis are required to form a correctly 
perforated primary mouth. To pinpoint the effects of Hh modulation on the oral 
opening, I examined a staged series of treated tadpoles (Fig 5.3). When I sectioned 
embryos at stage 22 and performed H&E staining on the samples I found that the 
amount of mesenchymal tissue between the endodermal and ectodermal epithelial 
sheets is doubled in cyclopamine treatment (yellow line, Fig 5.3G) compared to WT 
(yellow line, Figure 5.3A). This intervening tissue is decreased in purmorphamine 
treatments (yellow line, Figure 5.3M). This pattern continues in the stage 26 sections 
(yellow lines, Figure 5.3B,H&N). In all these embryos the ectoderm is a double-layered 
epithelium and appears unaffected by the treatments. At these stages the endoderm 
should be a continuous epithelial sheath (black arrowhead, Figure 5.3A-C & M-N) but in 
the cyclopamine treatment this structural integrity is absent at stages 22 and 26 (black 
arrowhead, Figure 5.3 G-H). 
 
By stage 28 there is premature contact between the endoderm and ectoderm in the 
purmorphamine treated tadpoles (blue arrowhead, Figure 5.3O); compare this to 
mesenchymal tissue still found between these two tissues in the WT (black arrowhead, 
Figure 5.3C). At stages 28 and 30, the cyclopamine treated animals that I examined had 
very disorganised endoderm with many loose cells apparent in the developing gut (black 
arrow, Figure 5.3J-K). Previous work from the Sive lab (Dickinson & Sive, DB, 2000) 
has shown that the presence of the endoderm is required for the perforation of the 
mouth. Indeed, the phenotype they describe, embryos lacking in a perforated mouth but 
with a small depression present, was found in a subset of our cyclopamine treated 

























5.2.5 Dramatic alterations to fibronectin suggests a mechanism for changes to 
the mouth  
 
 
Dickinson and Sive demonstrate clearly the loss of basement membrane over time in 
the developing stomodeum. This is critical for the perforation of the mouth, as the cells 
must lose the basal lamina so that the abutting ectoderm and endoderm cells can 
intercalate before dissolution. I found that changes in Hedgehog signaling resulted in 
altered fibronectin deposition (Figure 5.4). In WT conditions at stage 22, the mouth 
region is already losing fibronectin from the basement membrane at the site of the 
invaginating stomodeal depression (between yellow arrows, Figure 5.4A&D) compared 
to epithelium of the tissue below the cement gland.  In cyclopamine treated tadpoles, 
the cells in the stomodeum have not lost this basement membrane (blue arrow, Figure 
5.4B) but in purmorphamine treatments fibronectin levels are already reduced in this 
region, suggesting advanced progression in the formation of a mouth (yellow arrows, 
Figure 5.5C&F).  
 
The disorganised endoderm is also obvious at this stage in the cyclopamine treated 
embryos. The endoderm at this stage should be epithelial and characterized by long 
columnar cells.  β−catenin staining in the cells shows the lack of columnar cells in the 
endoderm of the cyclopamine treated (Figure 5.4H) compared to the ectoderm of the 
same sample or the endoderm of the WT (Figure 5.4G). In the purmorphamine 
treatments, the β−catenin localisation is mildly altered but the cell shape clearly shows 
the epithelial nature of the endoderm in this treatment (Figure 5.4I). 
 
At stage 26 the basement membrane should be absent from the region of the mouth 
(Dickinson and Sive, 2006). This was clear in the WT tadpoles at this stage (yellow 
arrow, Figure 5.4J).  In cyclopamine treated tadpoles there was residual fibronectin 
expression suggesting maintenance of a basal identity in the cells of the stomodeum 
(Figure 5.4K). If this is the case then no intercalation of the endoderm and ectoderm 
cells would be able to occur and the mouth would be unable to perforate. In contrast, 
purmorphamine incubation led the extensive disorganisation of the fibronectin staining 
suggests that the region where the endoderm and ectoderm cells can mingle and thin is 
enlarged, allowing for the formation of a drastically enlarged mouth (Figure 5.4L).  This 
thinning is required for the interaction of the two tissue types, resulting in perforation 
of the membrane (Waterman, 1985). Furthermore, it is possible that these changes lead 
to the inability of this tissue to displace to mesenchymal tissue between the endoderm 





























 5.2.6 Hedgehog is upstream of Wnt in regulating the levels of fibronectin in the 
developing mouth  
 
Dickinson and Sive clearly demonstrated that the levels of Wnt protein in the developing 
face affect the levels of fibronectin and laminin (Dickinson and Sive, 2009). Given the 
changes to the fibronectin deposition in the mouth with alterations in hedgehog 
signaling I asked whether Hh was acting in parallel with Wnt in this process or whether 
one was upstream of the other. The hypothesis based on our perforation and fibronectin 
data was that a loss of Hedgehog signaling would result in increased Wnt signaling and 
that the opposite would be true. To test this 100pg Wnt reporter construct super top 
flash was injected into the 2 anterior cells of a 4cell embryo. These embryos were treated 
with cyclopamine for 24 hours and a luciferase assay performed. We found that indeed 
inhibition of hedgehog signaling caused an increase in the levels of Wnt signaling in the 
embryo (Figure 5.5A).  
 
This was further confirmed by asking whether later up regulation of Wnt signaling could 
rescue the affects of early hedgehog up regulation. Increased Hedgehog signaling causes 
early contact between the ectoderm and endoderm in the region of the mouth, giving the 
enlarged mouth. Up-regulation of Wnt should increase fibronectin levels, preventing the 
perforation of the mouth. To test this, embryos were treated with purmorphamine at 
2cell and washed into BIO, a GSK-3 inhibitor that will increase β-catenin levels, either 12 
or 21hours post fertilization (Figure 5.5 E&G). Interestingly, only embryos treated with 
BIO at stage 19 (Figure 5.5E) showed any rescue of the enlarged mouth phenotype seen 
in embryos kept in purmorphamine (Figure 5.5C). BIO treatment from stage 12.5 alone 
causes a loss of the mouth, consistent with increased Wnt signaling. Purmorphamine 
followed by BIO at this stage also causes a complete loss of the perforated oral opening. 
Thus up regulation of Wnt was able to not only rescue the expected purmorphamine 
phenotype but was enough to completely obscure it with a Wnt up-regulation phenotype. 
BIO treatment at stage 19 has no effect on the size of the mouth (Figure 5.5F). In the 
tadpoles treated at stage 19 (21hpf) with BIO (Figure 5.5G) we found a reduction in the 
size of the mouth when compared to purmorphamine alone (Figure 5.5C) but it was still 
large compared to WT (Figure 5.5B) or BIO alone at this stage (Figure 5.5F). Control 
data not shown found that purmorphamine treatment between 2cell stages and stage 
12.5 results in an enlarged mouth. Taken together, this suggests that, consistent with 
previous studies, the mouth is sensitive to both loss and gain of Wnt until the tail bud 
stages but later, only the loss of Wnt signaling which results in a loss of basement 
membrane proteins, can perturb mouth size. These data also show that Wnt signaling is 
upstream of Hh in the anterior of the embryo in these early stages.  
 
 5.3 Discussion and conclusions 
 
 
I have shown a new and surprising requirement for Hedgehog signaling in the formation 
of a properly sized primary mouth. The loss of Hh results in a mouth where the cells of 
the endoderm and ectoderm do not come into contact at the appropriate stage and in a 
mouth that does not perforate. Excessive signaling causes premature contact between 
the two apposing tissues resulting in an enlarged mouth that opens prematurely. I 
believe my work shows that there is no specific region that is determined to be mouth 
(consistent with work from the Sive lab and studies in other organisms).  
 
The drastic changes seen suggest that localization of the primary mouth opening is 
closely associated with the amount of Hedgehog exposure. Clearly tight regulation on 
Hedgehog signaling in the anterior is required to ensure that the oral opening is both 
present and appropriately sized.  It is quite possible that Hedgehog activity is regulating 
Wnt signaling, which had previously been shown to be important in the primary mouth 
development (Dickinson and Sive, 2009).  In Shh-/- mouse mutants decreased Wnt 
signaling has been reported in the developing cloacal anlagen (Miyagawa et al., 2009). 
Therefore, the loss of sonic hedgehog signaling in the mouth may also result in a loss in 
Wnt signaling. Conversely, in conditions where Hedgehog signaling is increased we 
would expect to see a similar increase in Wnt signaling which would result in a larger 
mouth (Dickinson and Sive, 2009; Miyagawa et al., 2009).  
 
Premature loss of this fibronectin in the purmorphamine treated tadpoles may also be 
directly due to altered Wnt signaling. Expression of fibronectin is sensitive to levels of 
nuclear β−catenin. As it is changed, so is the amount of cell-cell or cell-substrate 
adhesion (Gradl et al., 1999).  
 
In deuterostomes, there are at least two regions in the body that form by dissolution of a 
membrane following intercalation of the ectoderm and endoderm: the mouth and the 
anus. Due to its catastrophic nature, a failure in primary mouth formation is unlikely to 
be observed in viable pregnancies. However, failure of the cloacal membrane to perforate 
does adversely affect a significant number of newborns. Studying the development of 
these tissues in mouse models is costly and time consuming. Xenopus may pose a 
relatively simple model in which to address development and perforation of these 
membranes. I propose that the oral opening in Xenopus could be used as a model to 
study the formation and eventual loss of this membrane as well as address the interplay 
between Hedgehog signaling and Wnt signaling in these tissues. This approach may 
provide insight into the development of various defects in the urogenital region in 
humans. It would be of interest to see whether the cloacal membrane behaves in a 
similar manner in these experiments. Initially, this could be addressed by examining 
whether embryos are capable of passing waste material from the stomach out through 
the proctodeum. However, given the severity of the mouth phenotypes embryos treated 
in cyclopamine or purmorphamine are unlikely to be capable of feeding or surviving 
much past stage 45 without feeding. In this instance, sections could be made through the 
posterior embryo to evaluate whether the cloacal membrane has a similar defect. If it 
does, the buccopharyngeal membrane could be used to assay any abnormal development 
in the dissolution of both membranes.  
 
Here though, in this simple model using basic washout, we were able to show that not 
only does Hh have a role in the opening of the mouth but also that Hedgehog signaling is 
also necessary and sufficient for this process, as loss of Hh prevents mouth formation 
while gain of Hh can counteract Wnts at later stages. This data, along with recent studies 
from the Sive lab, suggest that the oral opening in Xenopus may be a tractable model to 












6  GSK-3 IS REQUIRED FOR DEVELOPMENT OF 
ANTERIOR CRANIOFACIAL CARTILAGES  
 
6.1 Summary  
 
I have previously shown, in chapter four, that tadpoles treated with the GSK-3 inhibitor 
BIO lacked a subset of craniofacial cartilages. In this chapter, I analyze these phenotypes 
further. I show that GSK-3 inhibition by small molecule and morpholino oligonucleotide 
(MO) both perturb craniofacial cartilage development. Due to the earlier effects of the 
MO I returned to using BIO to finely control the timing of inhibition. By applying drug in 
increasingly shorter time periods, I narrowed down the minimal requirement for GSK-3 
in cartilage development as stages 12.5 -19.  Inhibition during this period perturbed a 
very specific region of the craniofacial cartilage while the rest of the embryo remained 
unaffected.  The most anterior neural crest is clearly more sensitive to the loss of GSK-3 
activity than the posterior neural crest. To track the migrating neural crest, I examined 
twist and sox 9 expression. To confirm that these phenotypes are indeed a result of BIO 
acting on GSK-3 and not off target effects, I first had to identify a full-length clone of 
Xenopus laevis GSK-3α. I then used this cDNA to analyze the expression pattern of GSK-
3α and design antisense morpholino oligonucleotides, in order to compare knockdown 
phenotypes with those seen in BIO treatments. Taken together, my data suggest that 
GSK-3 is required for appropriate migration of specific neural crest streams. Loss of 
GSK-3 activity leads to a loss of migration in the anterior streams, which correlates, with 
the cartilage defect found in stage 45 tadpoles.  
 
6.2 Introduction  
 
6.2.1 Glycogen Synthase Kinase 3  
 
GSK-3 (Glycogen synthase kinase 3) is a serine/threonine protein kinase initially 
discovered as a regulator of glycogen metabolism.  Since its discovery, GSK-3 has been 
suggested to regulate many processes beyond metabolism, including gene expression, 
cell cycle regulation, cell migration, development, oncogenesis and neuroprotection. 
GSK-3 plays a pivotal role in diseases as varied as cancer, Alzheimer’s disease and 
inflammation (Wang et al., 2011) (Wray et al., 2010) (Hur and Zhou, 2010) (Sun et al., 
2009).   
 
GSK-3 is evolutionarily conserved. In vertebrates, GSK-3 exists as two gene paralogues, 
GSK-3α and GSK-3β. GSK-3β is also known to have two splice isoforms, as does the 
Drosophila GSK-3 homologue (Mukai et al., 2002) (Schaffer et al., 2003) (Wood-
Kaczmar et al., 2009). Though GSK-3α and GSK-3β are structurally different, in most 
cases they are functionally redundant (Doble et al., 2007).  
 
Under resting conditions, GSK-3 is a constitutively active kinase. In the presence of 
active signaling, GSK-3 is usually inhibited. Inhibition of GSK-3 occurs primarily by 
activation of the PI3K/Akt pathway leading to n-terminal phosphorylation of GSK-3α 
(Serine 21) or GSK-3β (Serine 9) (Cross et al., 1995) (Cross et al., 1994) (Cross et al., 
1997). This inhibition is mediated by Akt (Martin et al., 2005) (Arbibe et al., 2000), PKC 
(Fang et al., 2002) (Ballou et al., 2001) PKB (van Weeren et al., 1998) or PKA (Fang et 
al., 2000) (Sheridan et al., 2002) (Tanji et al., 2002) and reviewed in (Harwood, 2001). 
Phosphorylation on the tyrosine residues Y216 and Y279 (in mammalian GSK-3α and 
GSK-3β respectively) results in enhanced GSK-3 activity but is not strictly required 
(Hughes et al., 1993). Along with such phosphorylation, GSK-3 activity can be regulated 
by other mechanisms such as subcellular localisation and interactions with protein 
complexes such as the destruction complex in the Wnt pathway. These protein 
complexes facilitate the actions of GSK-3 with specific substrates. (Jope and Johnson, 
2004) (Jope and Roh, 2006) (Ali et al., 2001) (Patel and Woodgett, 2008) (Gordon and 
Nusse, 2006) (Logan and Nusse, 2004)  
 
6.2.2 GSK-3 prefers pre-phosphorylated targets 
 
GSK-3 recognises the consensus sequence “Ser/Thr – X-X-X-X – SerP/ThrP” and its 
activity is in part controlled by the phosphorylation state of its targets. GSK-3 has been 
shown to have a 100-1000 fold stronger preference for pre-primed targets over 
unprimed substrates (Thomas et al., 1999) (Fiol et al., 1987) but typically, is not 
responsible for this pre-priming (reviewed in (Doble and Woodgett, 2007)). This 
preference for pre-phosphorylated substrates is linked to the phosphorylation of GSK-3 
itself. When arginine 96 is mutated to alanine, GSK-3β loses the ability to phosphorylate 
preprimed proteins but not those unprimed substrates (Frame et al., 2001). 
 
6.2.3 GSK-3 activity is regulated by numerous pathways  
 
GSK-3 acts in many different pathways including Wnt and insulin signaling. Its many 
targets include Gli, glycogen synthase, cyclin D1, tau and β−catenin (reviewed in (Frame 
and Cohen, 2001).  Because GSK-3 is active under normal resting conditions in the cell, 
it is generally inactivated for signaling to proceed. In many pathways, GSK-3 acts as a 
negative regulator. For example, in the context of insulin signaling, GSK-3 inhibits at 
least two proteins. The first, a guanine nucleotide exchange factor eIF2B, is important 
for controlling protein synthesis while the second is glycogen synthase, preventing 
glucose storage (Woodgett, 1994) (Welsh et al., 1998). In the presence of insulin ligand, 
GSK-3 must be shut down to allow downstream activation of eIF2B and glycogen 
synthase. Similarly, in the absence of Wnt ligand, GSK-3 phosphorylates β−catenin, 
targeting it for degradation. When Wnts are active, GSK-3 is inhibited and β−catenin can 
move to the nucleus and act as an transcriptional activator (reviewed (Doble and 
Woodgett, 2003)). With roles in so many different pathways it is likely that GSK-3 
activity is tightly regulated to prevent unwanted cross talk between pathways. Indeed, 
GSK-3 inhibition by insulin signaling does not affect the levels of nuclear β−catenin, 
suggesting that GSK-3 in the β−catenin destruction complex is buffered from such 
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inhibition. Conversely, insulin signaling appears unaffected by Wnt activation (Yuan et 
al., 1999) (Ding et al., 2000).  
 
While GSK-3 roles in insulin and Wnt signaling are well-established, it may also play 
roles in a variety of other pathways (Frame and Cohen, 2001).  Because the data for 
other pathways are less clear, I will not summarize them here. However, I will discuss 
GSK-3 roles in Hedgehog signaling in chapter 7. 
 
6.2.4 Chemical regulation of GSK-3  
 
A number of chemical inhibitors of GSK-3 are currently used in both a research and 
therapeutic capacity. The best known of these is lithium, which has been used for over 50 
years to treat patients with manic depression (bipolar disorder) (Phiel and Klein, 2001) 
(Jope, 1999). The activity of lithium on GSK-3 is complicated. Although Li+ can very 
rapidly inhibit GSK-3 by competing with active-site magnesium, the therapeutic value of 
lithium salts is seen only after treatment for a number of weeks. This suggests either that 
indirect inhibition of GSK-3 may be causing the desired long-term results in patients 
with mood disorders (De Sarno et al., 2002) or that Li has another target which causes 
the appropriate relief from mood disorder symptoms. However, in an unknown 
mechanism, inhibitory S9 phosphorylation on GSK-3β is increased after long-term 
administration of lithium (De Sarno et al., 2002). It is quite possible that GSK-3 is not 
the direct target of lithium at doses used to treat mood disorders, rather that its 
inhibition is a result of some other, indirect effect.  
 
Due to the unclear mode of action and great potential for off target effects, lithium 
inhibition of GSK-3 was not included in this study at all. For the chemical perturbations 
of GSK-3 discussed here, I used a small molecule inhibitor of GSK-3, BIO.  
 
GSK-3 is also being explored as a potential drug target in diabetes, Alzheimer’s and other 
diseases. In diabetes, inhibition of GSK-3 could regulate the rate at which glucose is 
made into glycogen in the liver. In Alzheimer’s disease, hyperphosphorylation of the tau 
protein by GSK-3 and other kinases is thought to affect disease progression (Hernández 
et al., 2010). A future challenge for chemists will be to design a GSK-3 inhibitor that 
selectively blocks phosphorylation of GSK-3 targets in specific pathways. While this has 
not yet been achieved, the current generation of compounds targeting GSK-3 are well 
characterised. These include inositol-phosphate phosphatases (Gould et al., 2004), 
paullones such as alsterpaullone (Chen et al., 2011; Leost et al., 2000; Tolle and Kunick, 
2011) and 6-bromo-substituted indirubins such as BIO (Meijer et al., 2003). BIO acts as 
a competitive inhibitor for GSK-3 ATP-binding, preventing GSK-3 from phosphorylating 
any target proteins. BIO shows a high specificity for GSK-3 (IC50 = 4nM) versus similar 
kinases such as CDK5 (IC50 = 83nM). Therefore, BIO is used extensively in this project 
(Meijer et al., 2003) (Polychronopoulos et al., 2004). 
 
6.2.5 Possible targets of GSK-3 during neural crest delamination and 
migration 
  
As outlined in the introduction, Wnt signaling plays a crucial role in induction of the 
neural crest. GSK-3 activity is important for the proper progression of this induction; 
however, less is known about subsequent steps in neural crest development. In part, this 
is due the lack of temporal resolution using previous methods such as overexpression 
and knockout. It is also worth remembering that all the pathways GSK-3 plays a role 
(Wnt, Hedgehog, TGF-beta) have been found to be important in the development of 
neural crest or neural crest derived structures (discussed later). In this project I wanted 
to bypass earlier effects and ask what role GSK-3 may be playing in later processes such 
as delamination and migration of neural crest cells.  GSK-3 has numerous downstream 
targets that may affect these events including cell cycle regulators -catenin and cyclin 
D1, substrates implicated in cell migration such as snail, and cytoskeleton regulators 






6.3.1 GSK-3 activity is critical for patterning the early embryo  
 
As demonstrated in chapters 3 and 4, proper timing of activity is crucial for correct 
patterning and development. The requirements for GSK-3 during gastrulation and early 
patterning are well established. Because later requirements are unclear, I exploited 
washout experiments to determine which processes required GSK-3 activity with respect 
to head and cartilage development.  
 
At stage 45, a normal tadpole has mobile eyes positioned bilaterally on either side of the 
cranial cartilage structures in the face. The cartilages are visible through the transparent 
skin of the tadpole (Figure 6.1 A).  As a positive control, embryos treated with BIO at the 
2-cell stage were cyclopic and lost anterior facial structures Eye defects were severe, 
resulting in the remnant of a single eye (Figure 6.1B). These results were consisted with 
an early loss of anterior neural patterning, as addressed previously in Figure 4.3. In 
contrast, treatment with BIO from stage 12.5 – 19 caused hypoplasia of a subset of 
craniofacial tissues. Eyes appeared normal; however, heads were narrow and eyes were 
set abnormally close to the brain (Figure 6.1C). When the drug was applied at stage 19, I 
found that although the head was slightly narrower and shorter, the tadpoles were 








 6.3.2 Washout experiments pinpoint stages 12.5 – 16 as a critical period for 
GSK-3 activity 
 
As previously described, we hypothesized that GSK-3 activity was important for some 
aspect of neural crest development especially as the facial structures described above rely 
on outgrowth of the cartilages, derived from the most anterior neural crest streams 
(chapter 4). To distinguish the critical stages, I performed washout experiments over a 
number of time points.  The data from these suggested that inhibition of GSK-3 activity 
from stage 12.5 to 23 led to changes in the head and face. To gauge the width of the head 
I measured between the eyes and at the widest point in the head (schematic, Figure 
6.2A). I also tried to compare the extent of facial growth by recording the length of the 
face from behind the eyes as well as the distance from the front of the eyes to the most 
anterior point (schematised in Figure 6.2B). When compared to WT and vehicle control I 
found that only the tadpoles treated between stages 12.5 – 23 were significantly 
narrower, averaging 0.4mM between the eyes and 1mM total width. This is less than half 
the width the controls and other treated samples, which ranged from 0.9mM-1.1mM 
between the eyes and 1.8mM-1.9mM total width (Figure 6.5A). This same treatment 
window also resulted in tadpoles that had facial truncations. By measuring from the 
posterior part of the eye to the anterior-most point in the face, I found that treatment 
from stage 12.5-23 reduced facial size by over 50%, from 0.8-0.95mM in controls to 
0.6mM. The majority of the tissue was lost in the region anterior to the eye, where the 
dimension changed from 0.5mM in controls to 0.25mM in treated tadpoles (Figure 
6.5B).  
 
Further experiments were conducted in shorter periods during the already identified 
critical period of 12.5 - 23. When GSK-3 was inhibited between stages 12.5 – 14 and 
stages 14 – 16 the tadpoles were smaller than those treated between the stages of 16 - 19 
and 19 – 23 in all the measurements taken (Figure 6.3A-C). Head size was dramatically 
reduced in the abbreviated treatments. The overall width of the tadpoles was reduced by 
25% in the tadpoles treated between stages 12.5-14 and by 40% in the stage 14-16 treated 
samples. Similar changes were seen in the length of the head: approximately 25% in the 
12.5-14 treatments and approximately 60% in the 14-16 treatments (Figure 6.3A). Again, 
these data suggest that the critical period of activity for GSK-3 encompasses both of 
these treatment periods. Interestingly we noticed that there was no significant change in 
the width of the tailfins in the BIO treated tadpoles, though this is also a neural crest 
derived tissue (Figure 6.3C). In all of these experiments a minimum of 18 embryos in 
each condition was measured and each experiment was repeated at least three times 





6.3.3 Numerous morphological changes were found with loss of GSK-3 
activity  
 
To conclude the gross morphological analysis, we scored for other morphological 
changes in these tadpoles (table 6.1). Defects included loss of ear ossicles, improperly 
perforated mouths and in some cases loss of nasal pits. As mentioned previously, scoring 
melanocyte development is challenging given the variation from clutch to clutch but it 
was apparent that some of these tadpoles had immature, round pigment cells. However, 
the phenotypes most dramatically changed were those relating to the craniofacial 
skeleton and midline.  
 
Table 6.1: Penetrance of phenotypic changes to the gross morphology of tadpoles 









WT DMSO BIO 
12.5 – 14 
BIO 
14 – 16  
BIO 
16 – 19 
BIO 
19 – 23 
Ossicles 
visible 
100 100% 50% 33% 92% 92% 
Melanocytes 
starred 
100% 100% 75% 42% 92% 92% 
Nasal pits 
visible 
100% 100% 84% 84% 92% 92% 




100% 100% 75% 50% 92% 92% 
Gut coiled  100% 100% 75% 92% 92% 92% 
 
6.3.4 BIO–induced truncation in the anterior ventral region is evident by 
stage 30 
 
Up to this point, our analysis had relied on late-stage phenotypic changes, which we 
examined some days after drug treatment. Clearly, it was important to identify more 
direct consequences of our experimental manipulations (adding BIO from stage 12.5-19). 
The first stage at which I could easily identify a morphological change in treated animals 
was stage 30 (Figure 6.8A). However it was not possible to accurately measure these 
changes by examining the length or width of the embryos as I had done with the stage 45 
tadpoles. When I measured embryos from the cement gland to the front of the face, from 
the posterior branchial arch to the front of the face and the width of the head at the 
posterior branchial arch I found no significant changes (Figure 6.4A). Instead, using the 
most posterior branchial arch (stained with twist) as a landmark, I documented changes 
to the anterior ventral head by measuring the area of this region in a lateral view (Figure 
6.4B-E). Consistent with the above measurements, length of face was unchanged and the 
anterior-posterior position of the cement gland had not shifted (Figure 6.4C-D) 
compared to WT (Figure 6.4B). However the area occupied by the stage 12.5 – 19 BIO 
treated embryos was clearly reduced in the anterior ventral region (yellow, schematic 
Figure 6.4E) compared to WT (dark green, Figure 6.4E) and stage 19+ BIO treated 
embryos (light green, Figure 6.4).  
 
The changes to the face are not due to a simple delay in development. Had the BIO 
resulted in globally delayed embryos it would have been apparent in the development of 
the tail bud. The embryos were not delayed in their development this structure, used to 
age embryos as per Nieuwkoop and Faber’s stages, and these were no different from the 
WT or DMSO treated embryos. This data is unsurprising given the relatively normal 
posterior embryo in the stage 45 tadpoles (see Chapter 3). The question at this point was 




6.3.5 Inhibition of GSK-3 between stages 12.5 – 19 does not affect neural 
crest induction  
 
As discussed earlier, one possibility is that treatment with a GSK-3 inhibitor results in 
inhibition of neural crest induction. To address this, I examined expression of the neural 
crest marker slug expression in embryos treated at stage 9 (during neural crest 
induction) and stage 12.5. Slug is the earliest identified gene expressed in the neural 
crest (Mayor et al., 1995) (Nieto et al., 1994). Indeed, treatment at stage 9 resulted in a 
very slight reduction in the lateral and posterior domains of the slug expression (Figure 
6.5B) compared to WT (Figure 6.5A). In the stage 12.5 treated embryos this posterior 
reduction was not present and the slug expression appears as normal (Figure 6.5D) when 
compared to WT (Figure 6.5C). These data suggest that indeed, GSK-3 activity is 
required for neural crest induction but that by stage 12.5, the window of sensitivity for 
loss of induction has past.  
 
6.3.6 GSK-3 inhibition does not perturb anterior-posterior patterning 
 
Another possibility is that changes to the anterior-posterior patterning of the neural 
plate because of altered Wnt signaling resulted in the posteriorization of the anterior 
neural plate. First, I examined markers for early eye development. The eye field is highly 
sensitive to any loss of anterior identity and I would predict that if GSK-3 inhibition 
posteriorized the embryo, expression of eye field markers would be lost (van de Water et 
al., 2001).  While the addition of BIO at stage 12.5 results in a midline defect, cyclopia is 
only seen in 10% of the tadpoles treated in this time window; the remaining 90% have 
close-set eyes (see Figure 6.1). Cyclopia has been proposed to be due to loss of the 
anterior midline. Because the majority of these animals had two eyes, it is unlikely that 
we have lost anterior or midline identity in these treatments (Durston et al., 1989) 
(Sampath et al., 1998) (Chiang et al., 1996) (Schier et al., 1996). To confirm that the eye 
field was dividing appropriately I examined the expression pax6, six3 and otx2 (Figure 
6.9C-E).  Pax6 is expressed in the eye field from stage 12, by stage 15 the expression is 
segregating and by stage 19 is clearly located in two distinct regions (Figure 6.5E-F).  The 
BIO treated embryos have two distinct fields of expression (Figure 6.5G).  Six3 
expression is unchanged in the BIO treatment (Figure 6.5J) compared to WT and 
controls (Figure 6.5H-I) as is otx2 expression (Figure 6.5K-M). Therefore, while the later 
































6.3.7 Anterior changes are due to a delay in neural crest migration  
 
Combined, the lack of changes to the induced neural crest at stage 19 along with the 
normal development of the eye field suggests that anterior – posterior patterning is not 
changed in these embryos. Based on phenotypes described above, I postulated that the 
induction of the neural crest was not lost and that the anterior identity was unchanged. 
Alterations in a number of processes could be causing the phenotype. The neural crest 
cells might not be delaminating, their migration into the face might be perturbed or the 
cells are might not be differentiating into cartilage.  
 
I examined twist expression, which marks migratory neural crest cells in embryos 
treated with BIO (stage 12.5 – 19) and fixed at stage 19, 23, and 30. In all the stages 
examined twist expression was found to be less extensive (Figure 6.6). At stage 19, there 
was a clear delay in the NCCs migrating out of the neural tube in the BIO treated 
embryos (Figure 6.6C) when compared to controls (Figure 6.6A-B). This continued in 
the embryos examined at stage 23 (Figure 6.6F). Each of the neural crest streams was 
affected and all appeared reduced. By stage 26, though cells in the anterior-most stream 
of NCCs are found surrounding the eye, there is clear reduction in the amount of staining 
















 6.3.8 Anterior defects correlate with a very specific loss in Sox9 expression 
 
Sox9 is expressed from about stage 14 in the developing neural crest . It continues to be 
expressed throughout delamination and migration of the neural crest, becoming 
localised to the cranial cartilages (O'Donnell et al., 2006).  The expression of sox9 is 
critical for cartilage formation.  When sox9 expression is lost in the neural crest, cartilage 
development is perturbed, resulting in malformed cranial cartilages (Spokony et al., 
2002).   
 
At stage 26, sox9 is strongly expressed in the developing otic placode, the eye and the 
brain along with the migrating neural crest of the WT and control embryos (Figure 6.7A-
B). In the BIO treated tadpoles, sox9 expression is slightly weaker in the eye and 
developing otic placode but is almost entirely lost in the neural crest (Figure 6.7C). By 
stage 33 this was even more apparent. The control embryos have Sox9 expression in 
stripes in the branchial arches (the gill cartilages will arise from this tissue) and very 
strong staining surrounding the eye and through the brain (Figure 6.7D-E). In the BIO 
treated embryos expression in the branchial arches is weaker, but present (Figure 6.7F). 
At stage 36 we can see clearly that the staining in the most posterior branchial arches of 
the BIO treated tadpoles has recovered (Figure 6.7I) and is comparable to the WT and 
control (Figure 6.7G-H). Contrast this with the staining that should be in the anterior 
regions beneath and above the cement gland. These regions are not developed and tissue 
is absent (Figure 6.7I). In a dorsal view of the stage 36 head it is very clear where the BIO 
treated tadpoles are dramatically affected (Figure 6.7L). The red arrow points out the 
sox9 expression in ventro-anterior to the forebrain and above the cement gland. In the 
control tadpoles this expression is evident but in the BIO treated tadpoles, this domain 
does not express Sox9. Furthermore, the cartilages associated with these regions are the 
same as those that were lost in the stage 45 tadpoles, consistent with our previous 
analysis.  Based on these data, we believe that GSK-3 is required for maintenance of 
anterior migratory neural crest. Selective loss of GSK-3 activity then leads to an 






6.3.9 Identification of full length GSK-3α 
 
One of the challenges of using a small molecule is the possibility that the phenotype 
examined is an artifact generated by off target effects. In order to confirm that the 
phenotype I was seeing was consistent with a loss of GSK-3 activity, I needed to compare 
BIO treatment with another knockdown method. To do this, I wanted to design 
morpholino oligonucleotides (MOs) to reduce Xenopus laevis GSK-3 protein.   Although 
both GSK-3α and GSK-3β were initially identified in 1995 (He et al., 1995), the complete 
GSK-3α cDNA had not been reported. Therefore, we set out to identify full-length GSK-
3〈. An expressed sequence tag (EST) clone, which contained the cDNA, was identified 
(AccNo: BA364215). Comparison to Xenopus laevis GSK-3 and to the genomic 
sequence of GSK-3〈 from Xenopus tropicalis confirmed a full-length insert for the cDNA 
sequence for X laevis GSK-3〈 (Figure 6.8) 
 
 
The coding region (in green, Figure 6.8) is 1215 nucleotides long. Our data included 268 
nucleotides of 5’UTR and 361 nucleotides of 3’UTR. Along with sequence alignments, a 
phylogenetic tree of human, mouse, zebrafish, Xenopus laevis and Xenopus tropicalis 
GSK-3α and GSK-3β was generated. It showed that the clone identified was closely 
related to the GSK-3〈 in the other species, more closely related to GSK-3 (Figure 6.9). 
Using NCBI alignment tools, I found that in X. laevis the sequence identity between 
GSK-3〈 and GSK-3 is 69%. The overall amino acid similarity between GSK-3〈 and GSK-
3 is 72.5%. As expected, the similarity in the kinase domain is much higher than 
outside the kinase domain (96%, schematised in Figure 6.8). Also conserved is the 
inhibitory serine at position 21 (red arrows, schematic Figure 6.10) The conserved 
activating tyrosine is be predicted at to be at position 233, based on the canonical 
phosphorylation motif “VSYIC” (green arrows, schematic Figure 6.10).  
 

Based on the sequence analysis in Figure 6.9, I designed two MOs targeting GSK-3α, 
one blocking the translational start site and another based on a putative intron-exon 
boundary (determined by alignment with Xenopus tropicalis GSK-3α). Morpholino 
oligonucleotides act to knock down gene function by preventing the proper translation 
of a protein from mRNA. They can do this in one of two ways, by interfering with the 
binding of the ribosome to the mRNA sequence at the start codon or by preventing the 
splicing of introns from the mRNA. Such misplaced mRNA is then not translated into 
protein (Draper et al., 2001; Heasman, 2002).  
A MO targeting the start site in GSK-3 had been previously described (Onai et al., 
2004). I also designed a GSK-3β splice-blocking MO. In order to assay the amount of 
GSK-3 protein in animals injected with MO, we performed western blot analysis 
(Figure 6.10B).  We found that the 1mM injection of MO’s resulted in a small reduction 
of GSK-3 on the western blot. Injections of a higher concentration were lethal to the 
developing embryo, suggesting that any more complete knock down of GSK-3 function 
was not compatible with life. Shown in Figure 6.10B are western blots on protein 
lysates from 3 embryos. The embryos were collected and lysed together in order to 
reduce any embryo variability. In embryos injected with all four MOs (labeled 
αα/ββMO) we can clearly see that the GSK-3α knockdown was more effective than 
GSK-3β, relative to loading control, HSP90 (Figure 6.10C).   
 
6.3.10 Treatment with BIO and GSK-3 MOs have comparable effects 
 
At this point, I wanted to compare the effect of BIO and morpholino oligonucleotides 
on a Wnt responsive luciferase reporter, SuperTOPFLASH (STF) (Mikels and Nusse, 
2006). This reporter contains multiple β−catenin dependent TCF/LEF binding sites 
driving expression of the firefly luciferase gene. This allows a quantitative assessment 
of Wnt/β−catenin activity under various conditions.  STF was injected into both cells of 
2-cell stage embryos and these were treated with various concentrations of BIO or co-
injected with combinations of GSK-3α and GSK-3β MOs (Figure 6.10A). The embryos 
were cultured until stage 14 when they were lysed for luciferase assays. Embryos were 
lysed in pools of 3 and a minimum of 9 pools used in each experiment.  I showed that 
BIO increased STF activity dramatically (in red, Figure 6.10). Increasing 
concentrations of BIO increased this response. At the highest doses (50uM) BIO 
incubations produced a massive response but killed the embryos within a few days. In 
MO treated embryos we can clearly see that inhibition of either GSK-3α or GSK-3β 
alone does not affect reporter activity (in navy, Figure 6.10). However, combining GSK-
3α and GSK-3β MOs produced a significant dose dependent induction of the reporter. 
Therefore, inhibition of both genes is required to activate Wnt/b-catenin signaling. In 
fact, the use of two α morpholinos and two β morpholinos was found to result in the 
most profound phenotype.  
 
To confirm that BIO’s effects on cartilage are due to loss of GSK-3 activity, I used the 
MO’s to examine the cartilage development in tadpoles where GSK-3 activity has been 
lost in the anterior of the embryo. MO knockdowns did indeed perturb cartilage 
development. MO’s were injected unilaterally into the anterior of a 4-cell embryo. 
These morphants were grown to stage 45 and examined for changes to cranial 
cartilages (schematised, Figure 6.11D).  I found that in both the α/β  set 1 and the 
αα/ββ MO injected tadpoles the craniofacial cartilages have been reduced, when 
compared to the control tadpoles (Figure 6.11A).  In the tadpoles injected with a single 
set of MOs Meckel’s cartilage and the palatoquadrate were reduced (Figure 6.11B). The 
cartilages are catastrophically disrupted in tadpoles injected with both sets of MO 
(αα/ββ) (Figure 6.11C). On the injected side, marked with a red star, most of the tissue 
is lost, of the anterior cartilages only a portion of the parahyoid on the non-injected 
side can be seen (yellow *, Figure 6.11C) and the cartilages surrounding the ear ossicle 












6.4 Discussion and Conclusions 
 
In this chapter, I have shown that GSK-3 has a role for patterning of the very anterior 
neural crest and that when GSK-3 activity is inhibited this anterior tissue is lost, 
resulting in dramatic and specific changes to the craniofacial cartilages.  To some 
extent, this is not surprising, as Wnt activation had already been implicated in early 
development. Indeed, early knockdown of GSK-3 activity (2-cell treatments) are 
reminiscent of dkk-1 knockdown mutants (Glinka et al., 1998).  In the dkk-1 mutant 
embryos Wnt inhibition in the anterior is lost and subsequently the head structures are 
lost.  What is more intriguing is the requirement of GSK-3 activity during periods of 
neural crest migration. This had not been previously characterized, in part because 
injection of mRNA or MOs does not allow that level of temporal refinement, and also 
because conditional mouse mutants have not previously been available. In fact, in the 
majority of experiments in this chapter, I used BIO exclusively to inhibit GSK-3 
activity, because it was technically impossible to do these experiments using the MOs. 
 
Specificity of the treatments 
 
To confirm that BIO treatment and MO injections are targeting Wnt/β-catenin 
signaling, I used a TCF/LEF responsive luciferase reporter. High levels of inhibition 
were toxic, suggesting that loss of GSK-3 activity results in catastrophic consequences 
during embryonic development. Indeed, knockout of both GSK-3 genes in the mouse 
leads to preimplantation lethality.  
 
Using intermediate doses of BIO and/or the MOs, we can assume that we are achieving 
a partial knockdown of GSK-3 activity. In this way, we can learn which processes or 
regions in the embryo are more sensitive to the loss of GSK-3. It is also possible that 
subcellularly, GSK-3 sequestration changes its drug accessibility. In fact it is known 
that protein interactions (such as those in the destruction complex) and cellular 
localisation (such as leading edge of growth cone) are important regulators of GSK-3 
activity (Green, 2004) (Dominguez and Green, 2001) (Dominguez and Green, 2000) 
(Sun et al., 2009). Thus, it is not inconceivable to imagine then that BIO is prohibited 
from acting on certain GSK-3 molecules at the expense of others depending on their 
binding and location. I think the very dramatic increase in luciferase activity in the 
50uM treated samples compared to the limited changes between the 15uM and 5uM 
treated samples supports this idea. Perhaps cytosolic GSK-3 or GSK-3 in other 
complexes is more readily available while GSK-3 in the Wnt destruction complex (with 
axin and APC) is only accessible at higher concentrations.    
 
What is GSK-3 doing in the neural crest?  
 
GSK-3 may have a number of roles in neural crest development between stages 12.5 – 
19. The absence of strong changes to slug expression suggest that induction of the 
neural crest is unaffected, supporting the hypothesis that the phenotype is caused by 
delayed EMT or delayed migration. Instead, GSK-3 activity is important in regulating 
the delamination and migration of neural crest. Several GSK-3 phosphorylation targets 
are important in neural crest delamination and migration including cyclin D1, -
catenin, TCF and snail/slug (Alt et al., 2000) (van Noort and Clevers, 2002) (Doble 
and Woodgett, 2003) (Burstyn-Cohen et al., 2004) (Zhou et al., 2004) (Zhou and 
Hung, 2005) (Doble and Woodgett, 2007).  Cyclin D1, a protein required for 
progression of the cell cycle from G1 to S phase, is a direct target of GSK-3. 
Phosphorylation by GSK-3 leads to the relocalisation and degradation of cyclin D1 
during S phase (Diehl et al., 1997). Inhibition of GSK-3 results in stabilisation and 
nuclear accumulation of cyclin D1 (Alt et al., 2000).  
 
GSK-3 may also phosphorylate multiple targets during epithelial to mesenchymal 
transitions (EMT). In epithelial cells, E-cadherin is down regulated during EMT. -
catenin, another direct target of GSK-3 phosphorylation, acts as a repressor of E-
cadherin transcription (Doble and Woodgett, 2007). A second target, Snail, is a zinc-
finger transcription factor that represses E-cadherin expression. Snail is also required 
for delamination. Phosphorylation by GSK-3 results in the nuclear export of snail and 
its degradation (Ko et al., 2007). Combined, these data suggest that GSK-3 is critical 
for EMT consistent with the observed delay in delamination. These events take place 
during the treatment window I describe and would result in the reported changes to 
sox9.  
 
Along with a possible role in delamination GSK-3 may also have a role in regulating cell 
migration (Eickholt et al., 2002). GSK-3 has been shown to be important in regulating 
neuronal responses to slit and robo during neuronal migration; therefore it is possible 
that GSK-3 has a similar role in neural crest migration. During neuronal migration, 
inactive GSK-3 is specifically maintained in the growth cone of neurons (Owen and 
Gordon-Weeks, 2003). Antagonists of GSK-3 have been shown to inhibit sema3 
dependent collapse of neuronal growth cones suggesting that tight regulation of 
active/inactive GSK-3 localisation is required for neuron outgrowth (Eickholt et al., 
2002). Although migrating neural crest cells do not have a growth cone they have an 
active protrusion (Jesuthasan, 1996).  It is unknown whether GSK-3 behaves similarly 
at this active protrusion in neural crest. However, if GSK-3 inhibition perturbed 
migration of the neural crest, I would have expected to see phenotypes in the tadpoles 
treated from stage 19 onwards. As this was not the case, it seems unlikely that 
phenotypes observed were due to the effect of GSK-3 activity on these putative cell 
protrusions. 
 
The Sox-9 phenotype is very dramatic. It is well documented that Sox-9 is required for 
cartilage development and is expressed in procartilagenous tissue.  There is a clear 
correlation between loss of anterior Sox-9 positive tissues with the later loss of 
cartilage. As I clearly highlighted, this change in Sox-9 expressing cells precedes a 
change in the anterior growth of the face and occurs after the reduction in twist 
positive cells migrating into the anterior face. As such, I believe that the later cartilage 
defect is due to an absence of tissue derived from the anterior most streams of neural 
crest. To this regard, I have overlooked the possible role for GSK-3 in regulating TGF-
beta in craniofacial cartilage development (Guo et al., 2008; Ito et al., 2002). While it 
has been shown that GSK-3 has a role in the regulation of TGF-beta signalling, TGF is 
required during the later stages of cartilage development, chondrogenesis (Guo et al., 
2008). I believe that the phenotype I have described here is different as the key 
window for GSK-3 requirement is too early for our experiments to have been directly 
perturbing chondrogenesis.  
 
This chapter has outlined for us a requirement for GSK-3 in facial development. 
Having identified this loss of tissue the question remains, what signaling pathways 
could be responsible? We have not addressed signals regulating GSK-3 in this context. 
In part, this is due to an assumption that GSK-3 roles in the early embryo are primarily 
regulating Wnt signal transduction. However, as described in the introduction, GSK-3 
plays pivotal roles in multiple signaling pathways. The following chapter addresses the 
challenges of deciphering potential roles for GSK-3 in the Hedgehog pathway, which 





































GSK-3, introduced in the previous chapter, is a highly promiscuous kinase that has the 
potential to play key regulatory roles in many signaling pathways. One such pathway is 
the Hedgehog (Hh) signaling pathway. In Drosophila, the Kruppel-like transcription 
factor Cubitus interruptus (Ci) is phosphorylated by the GSK-3 homologue shaggy 
leading to Ci degradation. This is a key step in the negative regulation of Hh signaling 
(Jia et al., 2002) (Price and Kalderon, 2002). It is unclear whether phosphorylation of 
Ci by GSK-3 leads to a similar role in vertebrates. In vertebrates the single Ci gene has 
diverged into three homologues (Gli1, Gli2 and Gli3). These proteins have different 
roles in modulation of the pathway and are differentially processed. Therefore, 
regulation of protein activity and stability is more complex. Many aspects, including 
the role of GSK-3 activity, are still unclear. Our lab is currently using several 
approaches, such as biochemical analysis, activity assays and mouse genetics to 
address these issues. 
 
At the protein level, Xenopus is the ideal model for testing the activity and processing 
of Gli proteins in response to GSK-3 modulation. By combining mRNA injection (Gli 
over-expression) and BIO treatment (GSK-3 inhibition), I am able to demonstrate a 
requirement for GSK-3 in reduction of Gli activity. When GSK-3 is inhibited by BIO, I 
see a dose dependent increase in Gli reporter responses as well as phenotypic readouts 
such as epithelial tumours. 
 
The data in this chapter are preliminary and comprise a small portion of a collaborative 
project. However, our results are novel and interesting. Therefore, I will describe the 
background evidence and provide an analysis of the current work. Necessary 
experiments and future work will be considered in the discussion. 
 
7.2 Introduction   
 
 
In the previous chapter I outlined the role for GSK-3 in the development of the anterior 
cartilages of the face. I showed that GSK-3 activity is essential for proper migration of 
the twist positive neural crest cells and for expression of Sox-9 in the pre-cartilaginous 
tissue. In this chapter I will ask how levels of GSK-3 activity affect Gli function.  
 
7.2.1 Hh signal transduction and GSK-3 
 
An overview of Hh signaling was presented in the introduction. Here I examine the 
evidence suggesting that GSK-3 may have a role in modulating signaling downstream 
of Hh. In Hedgehog signaling, there are two distinct forms of Ci: a full-length activator 
that is 155kD and a 75kD truncated repressor that lacks the c-terminal domain (Aza-
Blanc et al., 1997).  In Drosophila, the two different forms have distinct roles. For 
example, in the wing disc, a short repressor form is important in the anterior domain 
where it blocks the expression of a subset of Hh-responsive genes (Méthot and Basler, 
1999). In cells near the anterior-posterior boundary, the presence of Hh ligand inhibits 
Ci processing allowing full length Ci to translocate to the nucleus. Here it acts as a 
transcriptional activator driving expression of Hh target genes such as patched and 
engrailed  (Méthot and Basler, 1999)  
 
The truncation of Ci requires that the full-length protein be phosphorylated, a process 
that involves multiple kinases. Loss of the cAMP-dependent protein kinase A (PKA) is 
important in the proteolytic processing of Ci. PKA loss of function mutants have 
constitutively active Hh signaling (Pan and Rubin, 1995) (Li et al., 1995) (Lepage et al., 
1995) (Jiang and Struhl, 1995). PKA phosphorylates serine and threonine residues on 
the C-terminal end of Ci and this phosphorylation is essential for further processing 
(Wang and Holmgren, 1999) (Chen et al., 1999) (Price and Kalderon, 2002).  
 
More recently two other kinases have been suggested to act in the Hh pathway; GSK-3 
and casein kinase 1 (Jia et al., 2002) (Price and Kalderon, 2002). In vitro biochemical 
evidence suggests that GSK-3 can phosphorylate Ci. Inhibition of GSK-3 activity using 
LiCl reduced the levels of Ci phosphorylation in embryonic extracts and in cell culture 
(Klein and Melton, 1996) (Price and Kalderon, 2002) (Jia et al., 2002). 
In vivo, Jia et al. also showed that sgg mutants have mild Hh overactivation 
phenotypes including an accumulation of Ci-155, increased and mislocalised 
expression of Hh responsive genes, and anterior wing duplication.  Furthermore, loss 
of suppressor of fused (Sufu), a negative regulator of Hh signaling, further exacerbated 
the sgg phenotypes (see Figure 1.4).  Therefore, phosphorylation of Ci by shaggy 
appears to inhibit Ci function leading to an increase in hedgehog activity (Jia et al., 
2002) (Price and Kalderon, 2002).  
 
In vertebrates, Hh signals are mediated by three Gli orthologues: Gli1, Gli2 and Gli3. 
To further complicate matters, each Gli is regulated differently. Unlike Ci, which is 
cleaved from an activator form to a shorter repressor form, Gli1 does not contain a 
repressor domain and is therefore only able to act as an activator of Hh signaling (Dai 
et al., 1999). In contrast, Gli2 can be cleaved to the repressor form in vitro; however, 
this process is highly inefficient, suggesting that in vivo the vast majority of Gli2 
activity is as an activator (Pan et al., 2006). Instead, Gli2 appears to be highly regulated 
by degradation. In unstimulated cells, phosphorylation of Gli2 is dependent on PKA 
and other kinases (Pan et al., 2006). Hedgehog signal inhibits this degradation and 
allows Gli2 to translocate to the nucleus and induce transcription (Nguyen et al., 2005) 
(Bai et al., 2004; Lei et al., 2004).  Finally, Gli3 is very efficiently processed and is 
usually found in vivo as a truncated repressor. Indeed Gli3 does not rescue Gli2 
function when expressed in the Gli2 locus (Bai et al., 2004). In addition, alteration of 
any one of the six putative PKA sites in Gli3 completely blocks its processing in cell 
culture, suggesting that this Gli3 processing requires extensive phosphorylation at 
multiple sites (Wang et al. 2000). 
 
Mutations in the different Gli genes also demonstrate their functional divergence. Gli1 
was originally isolated from gliomas and is upregulated in many cancers including 
basal cell carcinoma (BCC) (Altaba et al.). Targeted over expression of Gli1 in the 
Xenopus ectoderm causes epithelial tumours, suggesting that Gli1 activity is sufficient 
to for tumorigenesis (Dahmane et al., 1997). However, mice with homozygous Gli1 
mutations appear normal, suggesting that Gli1 is not required for normal development 
(Park et al., 2000). Both Gli2 and Gli3 are required for embryonic development. Loss 
of Gli2 results in an array of developmental problems, with neural tube defects evident 



































In addition to playing critical roles during development, Hedgehog dysregulation is 
also associated with adult cancers such as basal cell carcinoma (BCC, reviewed in 
(Daya-Grosjean and Couvé-Privat, 2005)). BCC is a slow growing form of skin cancer 
that starts in the epidermis, which expresses Shh (Bitgood and McMahon, 1995; Chiang 
et al., 1999).  BCCs are the most common skin cancer, making up 75% of all diagnosed 
cases and affecting 750,000 people in the US each year (Epstein, 2008). Though most 
BCCs occur spontaneously, in almost all cases they arise from ectopic activation of Hh 
signaling. This may be due to Smo-activating mutations (Xie et al., 1998) (Lam et al., 
1999), inactivation of Ptch (Gailani et al., 1996) or in other proteins in the pathway 
such as SuFu (Reifenberger et al., 2005). In Xenopus, overexpression of Gli1 mRNA 
causes epithelial tumours (Dahmane et al., 1997). This activity can be used to assay the 















7.3 Results  
 
7.3.1 Inhibition of GSK-3 increases Gli-dependent reporter activity 
 
If GSK-3 is indeed an important regulator of vertebrate Hedgehog signaling, we should 
see a change in Gli-dependent transcriptional activation in response to BIO treatment. 
To do this, I used a Gli responsive luciferase reporter (GliBS, figure 7.2). Embryos were 
injected in both cells at the 2-cell stage with GliBS. As a positive control, we first tested 
this reporter activity in the presence of cyclopamine and purmorphamine, which 
inhibit and activate Hedgehog signaling respectively. As predicted, cyclopamine 
reduced the luciferase response while purmorphamine increased it in stage 14 embryos  
(p < 0.05, Figure 7.2A). At 5μM, 15μM and 50μM, BIO treatment resulted in a dose-
dependent increase in Gli-responsive luciferase activity, an almost 3-fold increase 
when embryos were incubated with 50μM BIO (p < 0.05, Figure 7.2A).  
 
7.3.1.1  Kinetics of Hedgehog response to BIO  
 
As described in the introduction, the Hedgehog pathway autoregulates by activating 
expression a feedback inhibitor, patched (Kalderon, 2000) (Taipale et al., 2002) 
(Rohatgi and Scott, 2007). This suggests that early activation of Hh signal 
transduction, seen at stage 14 above, might lead to loss of Hh target genes several 
stages later. Therefore, I treated embryos from stages 12.5 – 19 with BIO and examined 
ptc-2 expression at stages 19 and 21. Indeed, I found that expression of ptc-2 at stage 
21 was strongly reduced through the neural tube (Figure 7.2C, n=6) compared to 
controls (Figure 7.2A-B, n=4 & 5 respectively).  Expression in the very anterior region 
(presumptive eye field) is less perturbed. Hedgehog also controls expression of the 
ligand Shh. Again, I found that expression this target gene was reduced in response to 
BIO treatment (Figure 7.2 E-G) Taken together, these data suggest that initially, BIO 
treatment leads to an activation of Hedgehog signal transduction; feedback via the 
repressor Ptc leads to a subsequent loss of Hedgehog dependent genes. As mentioned, 
this data is preliminary so in order to fully quantify this response RT PCR is required to 
determine the actual changes in expression of Gli responsive genes at both time points. 
However it should be noted that Hh signaling is present and active in the embryo by 
stage 14 so the different response at stage 14 and stage 21 are not due to the absence of 












 7.3.2 GSK-3 inhibition increases Gli activator function 
 
As mentioned previously, ectopic hedgehog signaling causes BCCs. Similarly, injections 
of 2ng Gli mRNA targeted to the ectoderm resulted in tumour formation in most 
embryos (Dahmane et al., 1997). This provides a useful in vivo assay for Gli activity. To 
test for modulation of Gli activity I injected Gli mRNAs at subphenotypic levels 
(0.5ng). I could then culture with or without BIO at stage 9 and score for the presence 
of tumours, which can be identified as raised, darkened lumps on the injected flank of 
the embryo (see red arrows, Figure 7.3).  I found that in all cases inhibition of GSK-3 
increased the number of tumours, suggesting an increase in Gli activity. This was most 
obvious with Gli1 overexpression where over 80% of the injected BIO treated embryos 
developed tumours compared to 20% of the control embryos (Figure 7.3D, graphed, 
red columns).  Similar results were seen with Gli2 overexpression with 50% developing 
tumours after BIO treatment compared to 15% in controls (Figure 7.3F, graphed in 
blue).  Gli3 has been reported to cause tumours in this assay. We did observe similar 
effects with Gli3; however, the phenotype was comparatively weak, with only 30% 


















7.3.3 At cleavage stages, GSK-3 activity is required to repress Gli induced 
dorsalisation 
 
For many decades, Xenopus has been a powerful tool for studying early axial 
patterning. Common phenotypes include ultraviolet irradiation induced ventralisation, 
which leads to a loss of the dorsal organiser and lithium-induced hyperdorsalisation, 
which results in embryos with expanded cement glands and enlarged eyes. To easily 
score these phenotypes, Kao and Elinson (1988) developed a dorsoanterior index 
(DAI), ranging from 0 (ventralised) to 10 (dorsalised) (simplified in Figure 7.4, (Kao 
and Elinson, 1988)). 
  
Over expression of Gli mRNAs has not been reported to affect initial dorsal-ventral 
patterning of the early embryo. Early inhibition of GSK-3 by LiCl from (32-128 cell 
stages) strongly dorsalises embryos, resulting in phenotypes scoring 9 or 10 on the 
dorsoanterior index (DAI) (Cooke and Smith, 1988). Although BIO also inhibits GSK-3, 
we never see much dorsalisation at the concentrations used (Figure 7.4). This could be 
due to the doses used in our treatments, or to a different mode of drug action. 
 
To my surprise, Gli overexpression followed by early GSK-3 inhibition (at the 8-cell 
stage) resulted in severely hyperdorsalised animals (Figure 7.4D,F&H)’, DAI 
phenotypes scored in 7.4I). Neither individual treatment led to such dramatic 
phenotypes (Figure 7.4A-B). 
 
Clearly GSK-3 is required for dampening the Wnt signaling in the embryo (Dominguez 
and Green, 2000). It is possible that these DAI phenotypes were due to expansion of 
the dorsal identity via upregulation of Wnt. Indeed, I have previously shown that 
treatment with BIO induced β−catenin dependent STF activity, suggesting that Wnt 
signaling is upregulated in these treatments (Figure 6.3A). However, our BIO alone 
controls were, at best, mildly dorsalised  (Figure 7.4A-B).  
 
A second possibility is that increasing Hedgehog activity leads to hyperdorsalisation. 
However, we have also never observed these phenotypes when using Hedgehog 
modulators, either loss of function (cyclopamine), or gain of function 
(purmorphamine) (Chapter 5). This suggests that modulation of the Hedgehog 
pathway at the receptor level is insufficient for dorsalisation during cleavage stages, 
possibly due to a lack of endogenous Hh signal transduction. As a result, exogenous Gli 
is required to induce this dorsalisation activity. To address this, I compiled published 
microarray data on expression levels of Hedgehog pathway genes (Figure 7.5). 
Consistent with my hypothesis, most of these genes are not expressed prior to 
gastrulation. Sonic hedgehog and desert hedgehog are expressed at very low levels 
until stage 10 when there is a sharp increase (green and purple, Figure 7.5).  Indian 
hedgehog is not turned on until neurulation (yellow, Figure 7.5). The Gli genes 
maintain the same trend. The only gene that is expressed at high levels from 
fertilisation is the negative regulator Ptc1, supporting the idea that Hh signaling must 






















Discussion and conclusion 
 
Though preliminary, my data suggest that GSK-3 can modulate the Hedgehog pathway 
in vertebrates. Inhibition of GSK-3 causes an increase in Hh activity at both the 
transcriptional level and in Hh-dependent assays, such as induction of epithelial 
tumours. This chapter also demonstrates a previously unknown ability of GSK-3 to 
dampen Hh signaling in the early embryo, which may or may not be required 
endogenously.  As this project is ongoing, I will outline the current conclusions and some 
future work for this project.  
 
GSK-3 may have a role in controlling the cleavage of Gli from activator to repressor form 
in the absence of Hh ligand. Increased Gli-responsive signaling in the presence of BIO 
suggests that inhibition of GSK-3 does result in more activator Glis. The effect of BIO on 
the individual Gli proteins is less clear. Phenotypically, all three Gli proteins 
demonstrated increased “activator” function (in the form of epithelial masses) following 
BIO incubation. In the case of Gli2, which is most similar to Ci, GSK-3 should be 
regulating cleavage and degradation kinetics. When GSK-3 is inhibited, increased 
activity could be attributed to an increase in stable Gli2 protein. Similarly, in the case of 
Gli3, which is usually cleaved to a stable repressor form, GSK-3 inhibition may lead to 
some accumulation of full-length activator Gli3. However, as Gli1 is not normally cleaved 
to a short repressor form, GSK-3-dependent cleavage may not explain this increased 
activity. I hypothesize that GSK-3 may regulate stability of full-length activator Gli1.  
 
First, I will examine expression of Gli responsive genes by quantitative RT-PCR and by 
comparing GliBS reporter activity. I will also compare the effects of Gli overexpression in 
embryos response to BIO versus proteosome inhibitors. I would predict that if the 
increase in Gli activity in the presence of BIO was due to decreased degradation, I would 
be able to phenocopy this in embryos treated with a proteosome inhibitor. We should 
then be able to distinguish this from an increase in Gli activity due to decreased 
processing.   
 
A second interesting question that arises from my data is the possibility of temporal 
changes in GSK-3-dependent Hh signaling. As the Hh pathway autoregulates through 
patched expression, it is possible that in a 24hour experiment, such as those described in 
this chapter, immediate transcriptional changes will have been overlooked. To explore 
this further, I will confirm the kinetics of GliBS activation in response Gli proteins +/- 
BIO. To do this, I am examining immediate responses (one to three hours after BIO 
treatment) and compare to long-term responses (16 hours). I could further separate 
primary and secondary responses using a translational inhibitor such as cycloheximide. 
 
Finally, it would be important to acknowledge that the DAI phenotypes typically arise 
with excess Wnt. Here I show that severe DAI phenotypes are induced with early GSK-3 
inhibition in the presence of ectopic Gli. We could use this system to ask whether Hh is 
acting upstream of Wnt in this case or whether Hh signaling is capable of disrupting 






















8 FINAL SUMMARY 
 
My thesis is a study of temporal requirements for signaling pathways in development 
using the Xenopus laevis tadpole. To do this, I began by designing a pilot screen to test 
these signaling pathways in development of neural crest derived structures or 
craniofacial features. This screen then led me to identify previously unknown molecular 
requirements in several interesting biological processes: Hh in the development of the 
primary mouth, and GSK-3 in the patterning of the anterior cranial cartilages. Finally, I 
show preliminary experiments uncovering novel crosstalk between GSK-3 and Hedgehog 
signaling.  
 
I described the use of Xenopus tadpoles as an in vivo chemical biology assay.  This 
method has many advantages and we can learn much from using small molecules in this 
way. In combination with transgenic technology, such as GFP reporter animals, or 
overexpression assays, this could be a very powerful system. As an assay for craniofacial 
development, I think Xenopus has shown itself to be a useful developmental model. 
However, it has not been as possible to scale-up this project as intended. I had hoped 
that this type of screen could be performed using many hundreds if not thousands of 
chemicals. I believe the initial set up (embryos into dishes with timed application of 
drug) would be relatively straightforward. However there are a number of limitations.  
 
Firstly, each individual well needs to be kept rigorously clean so that the tadpoles can 
survive for the 7+ days it takes to reach feeding stages. In the treatments where drugs are 
applied for short periods of time and washed out, this does not pose too much of a 
problem as a complete solution change occurs at twice in the culture. In the experiments 
where incubation was for a longer period, for example in the 2 cell onwards treatments, 
embryos were cultured in the same media for a prolonged period of time and required 
twice daily monitoring to remove any dead embryos.   
 
Secondly, as the tadpoles grow, over crowding becomes more of an issue. In fact, I found 
that a maximum of 10 tadpoles per well in a 12 well plate developed successfully. When 
embryos were cultured in 24 well plates, up to 3 embryos would grow to stage 45. I did 
not find that the 48 well plates were compatible with culture to that late stage. By the late 
stage 30’s, even with only one individual per well, the embryos were dying. It may be 
possible that Xenopus tropicalis, smaller than X. laevis, could do better in the smaller 
wells to a later stage but that was beyond the scope of this project.  
 
Finally, because of the 3D nature of the stage 45 tadpoles, I believe that automated 
analysis of the in situ results or of the Alcian Blue cartilage staining or of the 
immunohistochemistry is not feasible at this point. As such, all scoring of phenotypes 
would be done manually. In my opinion this would limit the screen to fewer than 200 
drugs in order to allow the researcher time to score the various phenotypes of interest. 
Despite these limitations I think that if the small molecules were selected carefully then 
this type of screen can generate vast quantities of data, which is not so readily attainable 
in other systems. Perhaps if a smaller number of time points were chosen it would 
simplify the expansion of the screen and allow for refinement based on positive readouts 
as determined by the tissue or pathway of interest.  
 
These screens are quite data intensive. Even in the small screen I carried out two novel 
phenotypes were identified. The first shows a previously unidentified role for Hedgehog 
signaling in regulating the perforation and size of the primary mouth in Xenopus. I show 
that decreases in the levels of Hedgehog signaling reduce the size of the mouth and that 
increases expand the mouth dramatically. This is true until after stage 28, highlighting 
the late plasticity of this structure. Increased Hedgehog signal causes early contact 
between the ectoderm and endoderm, resulting in premature loss of basal lamina 
identity. Loss of Hedgehog alters cell shape in the endoderm and delays/inhibits 
perforation of the mouth.  
 
The second novel discovery is a narrow temporal requirement for GSK-3 signaling in the 
very anterior embryo that is essential for proper development of the craniofacial 
cartilages. GSK-3 inhibition during neurula stages perturbs neural crest cell migration, 
most strongly in the anterior. These changes to neural crest cell migration result in a loss 
of sox9 positive tissue and subsequent hypoplasia of the anterior cartilages, the 
infrarostral cartilage, Meckel’s cartilage and the palatoquadrate. This work proved very 
interesting and it would be quite possible to pursue it with the MO tools we designed and 
more targeted injections. However, the lab has, after many years of breeding, developed 
extensive mouse lines that provide a better tool to ask the more targeted questions of 
‘what role is GSK-3 playing in the delamination and migration of the neural crest’. A 
number of experiments that we discussed and determined to have value for this project, 
may be carried out by another student. In these, conditional knockouts plus both GSK-3 
mutants can be used to target specific tissues in the development of the murine NC. This 
project would likely have been too expensive to do without the support from the 
preliminary data from the Xenopus screen.  
 
Finally, as part of a larger collaborative project in our lab, I show that inhibition of GSK-
3 in Xenopus increases Gli-responsive luciferase activity and increases the number of Gli 
induced ”tumours”. This chapter also highlights further advantages to Xenopus as a 
model organism: how simple alterations in experimental design (addition of drug at an 
early time point, 8-cell stage, or later time point, stage 8) can be used to ask drastically 
different questions.  This project is ongoing so I have suggested some future work. Taken 
together with other work from the lab, these data should shed further light on potential 
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